MCID: STR008
MIFTS: 53

Strongyloidiasis

Categories: Gastrointestinal diseases, Infectious diseases, Neuronal diseases, Oral diseases, Rare diseases, Respiratory diseases, Skin diseases

Aliases & Classifications for Strongyloidiasis

MalaCards integrated aliases for Strongyloidiasis:

Name: Strongyloidiasis 12 75 53 59 55 3 44 15 17 72 33
Disseminated Strongyloidiasis 12 72 33
Anguilluliasis 59 72
Infection by Strongyloides 12
Threadworm Infection 53
Anguillulosis 59
Enterobiasis 72

Characteristics:

Orphanet epidemiological data:

59
strongyloidiasis
Inheritance: Not applicable; Age of onset: All ages;

Classifications:

Orphanet: 59  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:10955
ICD9CM 35 127.2
MeSH 44 D013322
NCIt 50 C128398
SNOMED-CT 68 1214006
ICD10 33 B78 B78.7 B78.9
MESH via Orphanet 45 D013322
ICD10 via Orphanet 34 B78.0 B78.1 B78.7 more
UMLS via Orphanet 73 C0038463 C0085810
Orphanet 59 ORPHA76
UMLS 72 C0038463 C0085810 C0086227 more

Summaries for Strongyloidiasis

CDC : 3 Strongyloidiasis is a disease caused by a nematode, or a roundworm, in the genus Strongyloides. Though there are over 40 species within this genus that can infect birds, reptiles, amphibians, livestock and other primates, Strongyloides stercoralis is the primary species that accounts for human disease. It sometimes infects primates, dogs and cats, and some dog and primate infecting strains have been shown to be capable of causing human infection. We do not know if cat-infecting strains can infect humans or not. The larvae are small; the longest reach about 600 µm in length-making them very difficult to see with the naked eye.

MalaCards based summary : Strongyloidiasis, also known as disseminated strongyloidiasis, is related to hypereosinophilic syndrome and ascaris lumbricoides infection, and has symptoms including fever and pruritus. An important gene associated with Strongyloidiasis is IL5 (Interleukin 5), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Albendazole and Diethylcarbamazine have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and t cells, and related phenotypes are hematopoietic system and digestive/alimentary

Disease Ontology : 12 A parasitic helminthiasis infectious disease that involves infection of the intestine, lungs, skin and central nervous system with nematode Strongyloides stercoralis.

NIH Rare Diseases : 53 Strongyloidiasis is a parasitic disease caused by the roundworm Strongyloides stercoralis (S. stercoralis). People catch the infection when they come in contact with soil contaminated with the worms. While there are often no symptoms, abdominal pain, cough, diarrhea, rash, unintentional weight loss and vomiting may occur. The infection is treated with anti-worm medications such as ivermectin. Strongyloidiasis is found in tropical and subtropical areas, but can also be found in temperate regions, including the southern United States.

Wikipedia : 75 Strongyloidiasis is a human parasitic disease caused by the nematode called Strongyloides stercoralis,... more...

Related Diseases for Strongyloidiasis

Diseases related to Strongyloidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 326, show less)
# Related Disease Score Top Affiliating Genes
1 hypereosinophilic syndrome 31.3 IL5 IL13 CCL11
2 ascaris lumbricoides infection 30.9 IL5 IL13
3 schistosomiasis 30.7 IL5 IL13 IFNG
4 giardiasis 30.6 TGFB1 CD79A
5 parasitic helminthiasis infectious disease 30.6 IL5 IL13
6 enterobiasis 30.6 IL5 IL13
7 cryptosporidiosis 30.4 CD79A CCL11
8 echinococcosis 30.3 IL5 IFNG
9 paragonimiasis 30.3 IL5 IL13
10 common variable immunodeficiency 30.3 IL5 IFNG CD79A
11 intestinal schistosomiasis 30.2 IL5 IL13
12 filariasis 30.0 IL5 IFNG
13 norwegian scabies 30.0 TGFB1 IL5
14 lung disease 30.0 TGFB1 IL5 IL13
15 lipoid nephrosis 30.0 IL13 CD79A
16 pulmonary disease, chronic obstructive 29.9 TGFB1 IL13 CCL11
17 folliculitis 29.9 IL5 IFNG CCL11
18 inflammatory bowel disease 29.8 TGFB1 IL13 IFNG
19 pneumonia 29.8 IL5 IL13 CCL11
20 onchocerciasis 29.8 IL5 IL13 CCL11
21 dermatitis 29.8 IL5 IL13 IFNG CCL11
22 ige responsiveness, atopic 29.7 IL5 IL13 IFNG
23 asthma 29.7 IL5 IL13 IFNG CCL11
24 idiopathic interstitial pneumonia 29.4 TGFB1 IL13 IFNG
25 human immunodeficiency virus type 1 29.4 IFNG CD4 CCL11
26 conjunctivitis 29.3 IL5 IL13 IFNG CCL11
27 bronchiolitis 29.3 IL5 IL13 IFNG CCL11
28 allergic hypersensitivity disease 29.3 IL5 IL13 IFNG CCL11
29 diarrhea 10.6
30 allergic contact dermatitis 10.5 IL5 IFNG
31 cow milk allergy 10.5 IL5 CD79A
32 milk allergy 10.5 IL5 CD79A
33 pemphigoid gestationis 10.5 IL5 CCL11
34 chronic meningitis 10.5 IL5 CCL11
35 cephalosporin allergy 10.5 IL5 IFNG
36 eosinophilic fasciitis 10.5 IL5 IFNG
37 eosinophilic gastroenteritis 10.5 IL5 CCL11
38 scleritis 10.5 IL5 IFNG
39 sporotrichosis 10.4 IFNG CD79A
40 atopic keratoconjunctivitis 10.4 IL5 IFNG
41 cytokine deficiency 10.4 IL5 IL13
42 chronic eosinophilic pneumonia 10.4 IL5 CCL11
43 angioimmunoblastic lymphadenopathy with dysproteinemia 10.4 IL5 IL13
44 respiratory syncytial virus infectious disease 10.4 IL5 IL13
45 meningitis 10.4
46 kimura disease 10.4 IL5 CCL11
47 inflammatory bowel disease 4 10.4 IL5 IL13
48 ileus 10.4
49 apple allergy 10.4 IL5 IL13
50 multicentric castleman disease 10.4 IL5 IFNG
51 microscopic colitis 10.4 IFNG CD79A
52 t-cell leukemia 10.4
53 leukemia, t-cell, chronic 10.4
54 latex allergy 10.4 IL5 IL13
55 toxic oil syndrome 10.4 IL5 IFNG
56 respiratory failure 10.4
57 chronic tic disorder 10.4 IL5 IL13
58 schistosoma mansoni infection, susceptibility/ 10.3
59 african tick-bite fever 10.3 IL13 IFNG
60 exanthem 10.3
61 nephrotic syndrome 10.3
62 paralytic ileus 10.3
63 penicillin allergy 10.3 IL13 IFNG
64 orofacial granulomatosis 10.3 IFNG CD79A
65 adult t-cell leukemia 10.3
66 urticaria 10.3
67 toxic shock syndrome 10.3
68 immune deficiency disease 10.3
69 constipation 10.3
70 pemphigus 10.3
71 bacterial meningitis 10.3
72 pollen allergy 10.3 IL5 IL13
73 proliferative glomerulonephritis 10.2 IFNG CD79A
74 dermatitis herpetiformis 10.2 CD79A CCL11
75 tuberculoid leprosy 10.2 TGFB1 IFNG
76 purpura 10.2
77 acquired immunodeficiency syndrome 10.2
78 peanut allergy 10.2 IL13 IFNG
79 ascaridiasis 10.2
80 paracoccidioidomycosis 10.2 IL5 IFNG
81 chronic active epstein-barr virus infection 10.2 TGFB1 IFNG
82 bullous pemphigoid 10.2 IL5 CD79A CCL11
83 mycoplasma pneumoniae pneumonia 10.2 IL13 IFNG
84 systemic lupus erythematosus 10.2
85 adult respiratory distress syndrome 10.2
86 lupus erythematosus 10.2
87 pemphigus vegetans 10.2
88 alcohol dependence 10.2
89 pemphigus vulgaris, familial 10.2
90 lymphoma 10.2
91 lymphocytic leukemia 10.2
92 dyspepsia 10.2
93 duodenitis 10.2
94 vasculitis 10.2
95 toxocariasis 10.2
96 angiostrongyliasis 10.1 IL5 IL13 CCL11
97 esophagitis, eosinophilic, 1 10.1 IL5 IL13 CCL11
98 eosinophilic meningitis 10.1 IL5 IL13 CCL11
99 eosinophilic gastritis 10.1 IL5 IL13 CCL11
100 chronic conjunctivitis 10.1 IL5 IL13 CCL11
101 rhinitis 10.1 IL5 IL13 CCL11
102 ocular cicatricial pemphigoid 10.1 TGFB1 CD79A
103 vernal keratoconjunctivitis 10.1 IL5 IL13 CCL11
104 radiculopathy 10.1 IL5 IL13 CCL11
105 conjunctival disease 10.1 IL5 IL13 CCL11
106 night blindness, congenital stationary, type 1a 10.1 IL5 IL13 CCL11
107 pulmonary eosinophilia 10.1 IL5 IL13 CCL11
108 eosinophilic pneumonia 10.1 IL5 IL13 CCL11
109 colitis 10.1
110 trichuriasis 10.1
111 duodenal ulcer 10.1
112 cystoisosporiasis 10.1
113 glomerulonephritis 10.1
114 peptic ulcer disease 10.1
115 human t-cell leukemia virus type 1 10.1
116 nasal cavity disease 10.1 IL5 IL13 CCL11
117 nose disease 10.1 IL5 IL13 CCL11
118 nickel allergic contact dermatitis 10.1 IL5 IL13 IFNG
119 common cold 10.1 IL5 IL13 CCL11
120 respiratory allergy 10.1 IL5 IL13 CCL11
121 bronchial disease 10.1 IL5 IL13 CCL11
122 urinary schistosomiasis 10.1 IL5 IL13 IFNG
123 pustulosis palmaris et plantaris 10.1 TGFB1 IL5 CD79A
124 stevens-johnson syndrome/toxic epidermal necrolysis 10.1 IL5 IL13 IFNG
125 food allergy 10.1 IL5 IL13 IFNG
126 cutaneous leishmaniasis 10.1 IL5 IL13 IFNG
127 leishmaniasis 10.1 IL5 IL13 IFNG
128 bacterial infectious disease 10.1
129 protein-losing enteropathy 10.1
130 leukemia 10.1
131 ancylostomiasis 10.1
132 t-cell adult acute lymphocytic leukemia 10.1
133 syndrome of inappropriate antidiuretic hormone 10.1
134 ankylostomiasis 10.1
135 hypersplenism 10.1 IFNG CD4
136 alveolar echinococcosis 10.1
137 pericarditis 10.1
138 coccidiosis 10.1
139 intestinal pseudo-obstruction 10.1
140 distomatosis 10.1
141 eosinophilia-myalgia syndrome 10.0 TGFB1 IL5 IFNG
142 blepharoconjunctivitis 10.0 SHE CCL11
143 tonsillitis 10.0 IFNG CD79A
144 clonorchiasis 10.0 TGFB1 IFNG CD79A
145 autoimmune disease 10.0
146 leukemia, chronic lymphocytic 10.0
147 leukemia, acute lymphoblastic 10.0
148 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.0
149 pancytopenia 10.0
150 membranoproliferative glomerulonephritis 10.0
151 pulmonary tuberculosis 10.0
152 duodenal obstruction 10.0
153 gastritis 10.0
154 peritonitis 10.0
155 intestinal obstruction 10.0
156 ulcerative colitis 10.0
157 bacterial pneumonia 10.0
158 amebiasis 10.0
159 47,xyy 10.0
160 leukemia, b-cell, chronic 10.0
161 pemphigus foliaceus 10.0
162 cytomegalovirus infection 10.0
163 diffuse alveolar hemorrhage 10.0
164 blepharitis 10.0 SHE CCL11
165 chronic graft versus host disease 9.9 IFNG CD79A CD4
166 enterocolitis 9.9
167 lymphoma, hodgkin, classic 9.9
168 myeloma, multiple 9.9
169 lymphoma, non-hodgkin, familial 9.9
170 aspergillosis 9.9
171 acute diarrhea 9.9
172 lung abscess 9.9
173 cardiac arrest 9.9
174 hydrocephalus 9.9
175 filarial elephantiasis 9.9
176 uveitis 9.9
177 klebsiella pneumonia 9.9
178 candidiasis 9.9
179 angioedema 9.9
180 gastroenteritis 9.9
181 agammaglobulinemia 9.9
182 acute kidney failure 9.9
183 myelitis 9.9
184 pustulosis of palm and sole 9.9
185 kidney disease 9.9
186 bronchitis 9.9
187 reactive arthritis 9.9
188 intestinal volvulus 9.9
189 crohn's disease 9.9
190 fascioliasis 9.9
191 psoriasis 9.9
192 48,xyyy 9.9
193 acute respiratory distress syndrome 9.9
194 congenital hydrocephalus 9.9
195 mollaret meningitis 9.9
196 polymyositis 9.9
197 hematopoietic stem cell transplantation 9.9
198 nonspecific interstitial pneumonia 9.9 TGFB1 IL13 IFNG
199 hydronephrosis 9.8
200 human immunodeficiency virus infectious disease 9.8 IFNG CD4
201 leukocyte disease 9.8 IL5 IL13 CD79A CCL11
202 pulmonary fibrosis, idiopathic 9.8 TGFB1 IL13 IFNG
203 tetanus 9.8 IL5 IL13 IFNG CD79A
204 allergic conjunctivitis 9.8 IL5 IL13 IFNG CCL11
205 keratoconjunctivitis 9.8 IL5 IL13 IFNG CCL11
206 upper respiratory tract disease 9.8 IL5 IL13 IFNG CCL11
207 bladder cancer 9.8
208 fibrosis of extraocular muscles, congenital, 1 9.8
209 myelopathy, htlv-1-associated 9.8
210 ovarian cancer 9.8
211 temporal arteritis 9.8
212 anemia, autoimmune hemolytic 9.8
213 lung cancer 9.8
214 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.8
215 thymoma, familial 9.8
216 gastrointestinal stromal tumor 9.8
217 mycobacterium tuberculosis 1 9.8
218 aplastic anemia 9.8
219 hepatitis c virus 9.8
220 mannose-binding lectin deficiency 9.8
221 bacteremia 1 9.8
222 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
223 hydrops, lactic acidosis, and sideroblastic anemia 9.8
224 diarrhea 9 9.8
225 bacterial sepsis 9.8
226 anaplastic large cell lymphoma 9.8
227 lymphoplasmacytic lymphoma 9.8
228 immunoglobulin alpha deficiency 9.8
229 ileocolitis 9.8
230 inguinal hernia 9.8
231 drug allergy 9.8
232 lymphoblastic lymphoma 9.8
233 cysticercosis 9.8
234 endocarditis 9.8
235 microinvasive gastric cancer 9.8
236 meningoencephalitis 9.8
237 steatorrhea 9.8
238 interstitial nephritis 9.8
239 gastric ulcer 9.8
240 dirofilariasis 9.8
241 microcytic anemia 9.8
242 portal vein thrombosis 9.8
243 cryptococcosis 9.8
244 pica disease 9.8
245 balantidiasis 9.8
246 acute leukemia 9.8
247 focal segmental glomerulosclerosis 9.8
248 acute cystitis 9.8
249 allergic bronchopulmonary aspergillosis 9.8
250 intestinal tuberculosis 9.8
251 urethritis 9.8
252 loiasis 9.8
253 opisthorchiasis 9.8
254 obstructive hydrocephalus 9.8
255 oral candidiasis 9.8
256 sclerosing cholangitis 9.8
257 rheumatic disease 9.8
258 viral hepatitis 9.8
259 enthesopathy 9.8
260 nocardiosis 9.8
261 psychotic disorder 9.8
262 parasitic protozoa infectious disease 9.8
263 necatoriasis 9.8
264 bronchiolitis obliterans 9.8
265 acute pancreatitis 9.8
266 iga glomerulonephritis 9.8
267 adenocarcinoma 9.8
268 glioblastoma multiforme 9.8
269 proctitis 9.8
270 tropical spastic paraparesis 9.8
271 thymoma 9.8
272 haemonchiasis 9.8
273 inappropriate adh syndrome 9.8
274 pulmonary fibrosis 9.8
275 arthropathy 9.8
276 liver disease 9.8
277 hyperglycemia 9.8
278 hypokalemia 9.8
279 rapidly progressive glomerulonephritis 9.8
280 pancreatitis 9.8
281 infertility 9.8
282 intestinal disease 9.8
283 acute t cell leukemia 9.8
284 hemolytic anemia 9.8
285 severe combined immunodeficiency 9.8
286 b-cell lymphoma 9.8
287 active peptic ulcer disease 9.8
288 chronic kidney disease 9.8
289 scabies 9.8
290 appendicitis 9.8
291 corneal ulcer 9.8
292 cholangitis 9.8
293 trichinosis 9.8
294 polyarteritis nodosa 9.8
295 toxoplasmosis 9.8
296 cutaneous larva migrans 9.8
297 eosinophilic pustular folliculitis 9.8
298 glioblastoma 9.8
299 glioma 9.8
300 htlv-1 associated myelopathy/tropical spastic paraparesis 9.8
301 lymphangiectasis 9.8
302 pemphigus and fogo selvagem 9.8
303 pustular psoriasis 9.8
304 spastic paraparesis 9.8
305 depression 9.8
306 back pain 9.8
307 chronic pain 9.8
308 dysphagia 9.8
309 encephalopathy 9.8
310 headache 9.8
311 posttransplant acute limbic encephalitis 9.8
312 glial tumor 9.8
313 secondary hemophagocytic lymphohistiocytosis 9.8
314 infective dermatitis associated with htlv-1 9.8
315 pemphigus erythematosus 9.8
316 glomerular disease 9.8
317 overgrowth syndrome 9.8
318 proteasome-associated autoinflammatory syndrome 1 9.8 IL5 IL13 IFNG CCL11
319 allergic asthma 9.8 IL5 IL13 IFNG CCL11
320 dermatitis, atopic 9.7 IL5 IL13 IFNG CCL11
321 allergic rhinitis 9.7 IL5 IL13 IFNG CCL11
322 esophagitis 9.7 TGFB1 IL5 IL13 CCL11
323 paranasal sinus disease 9.6 TGFB1 IL5 IL13 IFNG
324 skin disease 9.4 IL5 IL13 IFNG CD79A CCL11
325 respiratory system disease 9.3 TGFB1 IL5 IL13 IFNG CCL11
326 malaria 9.2 TGFB1 IL5 IL13 IFNG CCL11

Graphical network of the top 20 diseases related to Strongyloidiasis:



Diseases related to Strongyloidiasis

Symptoms & Phenotypes for Strongyloidiasis

UMLS symptoms related to Strongyloidiasis:


fever, pruritus

MGI Mouse Phenotypes related to Strongyloidiasis:

46 (showing 4, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.76 CCL11 CD4 CD53 CD79A IFNG IL13
2 digestive/alimentary MP:0005381 9.65 CD4 IFNG IL13 IL5 TGFB1
3 immune system MP:0005387 9.56 CCL11 CD4 CD53 CD79A IFNG IL13
4 respiratory system MP:0005388 9.02 CCL11 IFNG IL13 IL5 TGFB1

Drugs & Therapeutics for Strongyloidiasis

Drugs for Strongyloidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 17, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Albendazole Approved, Vet_approved Phase 3 54965-21-8 2082
2
Diethylcarbamazine Approved, Investigational, Vet_approved Phase 3 90-89-1 3052
3
Azithromycin Approved Phase 3 83905-01-5 447043 55185
4 Tubulin Modulators Phase 3
5 Antimitotic Agents Phase 3
6 Antiprotozoal Agents Phase 3
7 Lipoxygenase Inhibitors Phase 3
8 Anti-Bacterial Agents Phase 3
9
Ivermectin Approved, Investigational, Vet_approved Phase 2 70288-86-7 6474909
10 Antiparasitic Agents Phase 2
11 Anti-Infective Agents Phase 2
12 Anthelmintics Phase 2
13 Milbemycin Phase 2
14
Formaldehyde Approved, Vet_approved 50-00-0 712
15
Mebendazole Approved, Vet_approved 31431-39-7 4030
16 Disinfectants
17 Ether

Interventional clinical trials:

(showing 12, show less)
# Name Status NCT ID Phase Drugs
1 Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis Completed NCT01570504 Phase 3 Ivermectin
2 Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis Completed NCT00765024 Phase 3 Ivermectin;ivermectin;Albendazole
3 A Cluster Randomised Trial of the Safety of Co-Administration of IDA (Ivermectin, Diethylcarbamazine and Albendazole) & Azithromycin for Integrated Treatment of Neglected Tropical Diseases Completed NCT03676140 Phase 3 Albendazole on Day 1;Ivermectin on Day 1;Diethylcarbamazine on day 1;Azithromycin on Day 1;Azithromycin on Day 8
4 A Comparative Study of Two Regimens of Ivermectin for the Treatment of Strongyloides Stercoralis Infection Recruiting NCT03605758 Phase 3 Ivermectin
5 Efficacy, Safety and Pharmacokinetics of Ascending Dosages of Moxidectin Alone and in Comparison to Ivermectin Against Strongyloidiasis Stercoralis in Adults: a Randomized Controlled Trial Not yet recruiting NCT04056325 Phase 2 Moxidectin;Ivermectin;Placebo oral tablet
6 Community-based Approach for the Management of Soil-transmitted Helminthiasis in General and Strongyloidiasis in Particular in a Highly Endemic Area Unknown status NCT01308268 Ivermectin + Albendazole
7 Study of Patients With Known or Suspected Infection With Strongyloides Stercoralis Completed NCT00001245
8 Diagnosis of Neglected Tropical Diseases (NTDs) in Patients Presenting With Persistent Digestive Disorders (≥2 Weeks) in Côte d'Ivoire, Indonesia, Mali and Nepal Completed NCT02105714
9 Host Response to Infection and Treatment in Lymphatic Filarial Disease Strongyloidiasis in India Completed NCT00342576
10 Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren Completed NCT00207753 albendazole vs. combined albendazole/ivermectin treatment
11 The Sero-prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands Completed NCT01080989
12 Study of Patients With Parasitic Infections of the Gastrointestinal Tract Terminated NCT00001162

Search NIH Clinical Center for Strongyloidiasis

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Albendazole
Ivermectin
Mebendazole
Mebendazole
Pyrantel
Pyrantel Pamoate
Thiabendazole

Cochrane evidence based reviews: strongyloidiasis

Genetic Tests for Strongyloidiasis

Anatomical Context for Strongyloidiasis

MalaCards organs/tissues related to Strongyloidiasis:

41
Skin, Testes, T Cells, Lung, Eye, Kidney, Small Intestine

Publications for Strongyloidiasis

Articles related to Strongyloidiasis:

(showing 1816, show less)
# Title Authors PMID Year
1
Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. 9 38
19513105 2009
2
Eosinophil-selective mediators in human strongyloidiasis. 9 38
16879311 2006
3
The mutual influence of nematode infection and allergy. 9 38
16210900 2006
4
Strongyloides ratti antigenic components recognized by IgE antibodies in immunoblotting as an additional tool for improving the immunodiagnosis in human strongyloidiasis. 9 38
15057354 2004
5
Heterologous antigen extract in ELISA for the detection of human IgE anti-Strongyloides stercoralis. 9 38
14743666 2003
6
Immunoglobulin-E and anti-IgE treatment in lung disease. 9 38
11980283 2001
7
A three years follow-up of total serum IgE levels in three patients treated for strongyloidiasis. 9 38
11802274 2001
8
Influence of human T-cell lymphocytotropic virus type 1 infection on serologic and skin tests for strongyloidiasis. 9 38
11716123 2001
9
HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. 9 38
11589779 2001
10
L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output. 9 38
10587378 1999
11
Differentially enhanced cytokine gene expression in CD4+ and CD8+ T cells in mesenteric lymph nodes in rats infected with Nippostrongylus brasiliensis. 9 38
10610496 1999
12
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. 9 38
9815251 1998
13
Humoral responses in human strongyloidiasis: correlations with infection chronicity. 9 38
9463683 1997
14
Total serum IgE and parasite-specific IgG and IgA antibodies in human strongyloidiasis. 9 38
8115797 1993
15
Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. 9 38
1543206 1992
16
Highly specific and sensitive anti-Strongyloides venezuelensis IgY antibodies applied to the human strongyloidiasis immunodiagnosis. 38
31128257 2019
17
Parasitic infections in Malaysian aborigines with pulmonary tuberculosis: a comparative cross-sectional study. 38
31363922 2019
18
First molecular identification of Strongyloides fuelleborni in long-tailed macaques in Thailand and Lao People's Democratic Republic reveals considerable genetic diversity. 38
30027858 2019
19
Ivermectin: From theory to clinical application. 38
31071469 2019
20
Case Report: Two Cases of Strongyloidiasis Presenting with Thrombotic Events. 38
31218995 2019
21
Lateral Flow Dipstick Test for Serodiagnosis of Strongyloidiasis. 38
31218996 2019
22
Strongyloides stercoralis Infection at Different Altitudes of the Cusco Region in Peru. 38
31264557 2019
23
Utility of PCR in Patients with Strongyloides stercoralis and HTLV-1 Coinfection in French Guiana. 38
31436152 2019
24
Detection of classic and cryptic Strongyloides genotypesby deep amplicon sequencing: A preliminary survey of dog and human specimens collected from remote Australian communities. 38
31430282 2019
25
Septic Meningitis and Liver Abscess due to Hypermucoviscous Klebsiella pneumoniae Complicated with Chronic Strongyloidiasis in a Human T-lymphotropic Virus 1 Carrier. 38
31434825 2019
26
Clinical and Diagnostic Features of 413 Patients Treated for Imported Strongyloidiasis at the Hospital for Tropical Diseases, London. 38
31219002 2019
27
Methotrexate exposure and risk of strongyloidiasis. 38
31302948 2019
28
Strongyloidiasis hyperinfection after renal transplant presenting as diffuse alveolar hemorrhage with respiratory failure. 38
31384205 2019
29
Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin. 38
31279610 2019
30
Corticosteroid-induced immunodeficiency in a patient with gliomatosis cerebri: Are corticosteroids indicated in all brain tumors? 38
30964431 2019
31
Strongyloides stercoralis infection in human immunodeficiency virus-infected patients and related risk factors: A systematic review and meta-analysis. 38
31359566 2019
32
Prevalence and risk factors of Strongyloides stercoralis infection among Orang Asli schoolchildren: new insights into the epidemiology, transmission and diagnosis of strongyloidiasis in Malaysia. 38
31303180 2019
33
Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012-2017). 38
31363770 2019
34
The Anthelmintic effect on Strongyloides venezuelensis induced by BnSP-6, a Lys49-phospholipase A2 homologue from Bothrops pauloensis venom. 38
31340738 2019
35
HTLV-1-associated adult T-cell leukemia/lymphoma with disseminated strongyloidiasis. 38
31196878 2019
36
Microfilaria and Strongyloides larva diagnosed in cerebrospinal fluid and ascitic fluid, respectively: Approach to their morphology on cytology. 38
31211515 2019
37
Disseminated Strongyloidiasis. 38
31188402 2019
38
Strongyloidiasis in Ethiopia: systematic review on risk factors, diagnosis, prevalence and clinical outcomes. 38
31200770 2019
39
Strongyloides stercoralis in Patients on Corticosteroids Therapy Using Enzyme-Linked Immunosorbent Assay and Gelatin Particles Indirect Agglutination Tests: A Diagnostic Approach. 38
31069645 2019
40
Morbidity Associated with Chronic Strongyloides stercoralis Infection: A Systematic Review and Meta-Analysis. 38
30963990 2019
41
Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease. 38
31263320 2019
42
Serodiagnosis and early detection of Strongyloides stercoralis infection. 38
30482708 2019
43
Parasitic Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient, Including Toxoplasmosis and Strongyloidiasis. 38
31005139 2019
44
Production of recombinant 14-3-3 protein and determination of its immunogenicity for application in serodiagnosis of strongyloidiasis. 38
30856271 2019
45
Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017). 38
31095570 2019
46
Disseminated strongyloidiasis in an immunocompetent male: A Case Report. 38
31105313 2019
47
[Screening the asymptomatic traveler returning from the tropics]. 38
31050236 2019
48
A case report suggestive of strongyloidiasis infection occurring in temperate Australia. 38
31084034 2019
49
Comparison of ELISA and PCR of the 18S rRNA gene for detection of human strongyloidiasis using serum sample. 38
30773081 2019
50
Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review. 38
31123976 2019
51
Characterization of a non-sexual population of Strongyloides stercoralis with hybrid 18S rDNA haplotypes in Guangxi, Southern China. 38
31059500 2019
52
[Recommendations for the screening for infectious diseases, mental health, and female genital mutilation in immigrant patients seen in Primary Care]. 38
31029458 2019
53
Disseminated Strongyloidiasis: Breaking Brain Barriers. 38
31007445 2019
54
Implementation of a Strongyloides screening strategy in solid organ transplant donors and recipients. 38
30773692 2019
55
In vitro anthelmintic activity of Siparuna guianensis extract and essential oil against Strongyloides venezuelensis. 38
30973122 2019
56
Strongyloidiasis: A Neglected Tropical Disease. 38
30712758 2019
57
[Strongyloidiasis, a sexually transmitted disease]. 38
30853289 2019
58
Migration Medicine. 38
30712766 2019
59
Donor-derived strongyloidiasis in a Saudi pediatric kidney transplant recipient: A case report and mini-review. 38
30578622 2019
60
Strongyloides stercoralis infection: A systematic review of endemic cases in Spain. 38
30860995 2019
61
Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. 38
30683241 2019
62
Strongyloidiasis and schistosomiasis: lessons from migrants' data. 38
30683227 2019
63
Hemoptysis in the Immunocompromised Patient: Do Not Forget Strongyloidiasis. 38
30759812 2019
64
Lethal strongyloidiasis - Diagnostic and forensic issues. 38
30738288 2019
65
Donor-derived strongyloidiasis after organ transplantation in Norway. 38
30295406 2019
66
The investigation of Strongyloides stercoralis seroprevalence in immunosupressed patients in Turkey 38
30761833 2019
67
The Experimental Infections of the Human Isolate of Strongyloides Stercoralis in a Rodent Model (The Mongolian Gerbil, Meriones Unguiculatus). 38
30764580 2019
68
IgG reactivity with 40-35 kDa soluble and membrane antigen of Strongyloides venezuelensis in immunocompromised patients. 38
30552879 2019
69
[Duodenal obstruction by Strongyloides stercoralis, an unusual complication]. 38
31095209 2019
70
Efficacy of ivermectin to control Strongyloides stercoralis infection in sheltered dogs. 38
30465740 2019
71
Strongyloides venezuelensis infection augments arterial blood pressure in male wistar rats. 38
30529092 2019
72
Case Report: Central Nervous System Strongyloidiasis: Two Cases Diagnosed Antemortem. 38
30457095 2019
73
Diagnostic update for an unusual case: recurrent strongyloidiasis. 38
30636686 2019
74
Fatty acid and retinol-binding protein: A novel antigen for immunodiagnosis of human strongyloidiasis. 38
31329601 2019
75
[Strongyloides hyperinfection in patient from Patagonia with HTLV-1 co-infection]. 38
31048281 2019
76
Strongyloidiasis Presenting as Yellowish Nodules in Colonoscopy of an Immunocompetent Patient. 38
30157619 2019
77
Evaluation of the inhibitory effect of ivermectin on the growth of Babesia and Theileria parasites in vitro and in vivo. 38
31337949 2019
78
[About a Case of Febrile Gastroenteritis Due to Strongyloidiasis in a Gabonese Patient Treated for Lupus]. 38
31225731 2019
79
OCCASIONAL DIGESTIVE HEMORRHAGE IN CHILDREN DUE TO STRONGYLOIDIASIS: IMPORTANCE OF PARASITOLOGIC TESTING. 38
30066826 2019
80
Sequential Changes in the Host Gut Microbiota During Infection With the Intestinal Parasitic Nematode Strongyloides venezuelensis. 38
31293983 2019
81
Influence of parasite load on the diagnosis and occurrence of eosinophilia in alcoholic patients infected with Strongyloides stercoralis. 38
29179791 2019
82
Epidemiology of Strongyloides stercoralis infection in Bolivian patients at high risk of complications. 38
30653489 2019
83
Screening of Strongyloides infection using an ELISA test in transplant candidates. 38
31188909 2019
84
Strongyloides stercoralis infection in San Marino Republic: first epidemiological data from an observational study. 38
31364552 2019
85
Strongyloides infection as a reversible cause of chronic urticaria. 38
30881049 2019
86
Implementation and evaluation of a quality and safety tool for ambulatory strongyloidiasis patients at high risk of adverse outcome. 38
30988956 2019
87
Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols. 38
30398144 2019
88
Case Report: Strongyloides stercoralis Hyperinfection in a Patient with HTLV-1: An Infection with Filariform and Rhabditiform Larvae, Eggs, and Free-Living Adult Females Output. 38
30277207 2018
89
Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review. 38
30577567 2018
90
Case Report: Subcutaneous Ivermectin Pharmacokinetics in Disseminated Strongyloides Infection: Plasma and Postmortem Analysis. 38
30334520 2018
91
Disseminated Strongyloidiasis. 38
30665485 2018
92
Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review. 38
30353268 2018
93
A case of chronic strongyloidiasis diagnosed by histopathological study. 38
30261269 2018
94
Enterobius vermicularis infection mimicking strongyloidiasis: A case report. 38
30190233 2018
95
Challenge in the diagnosis of pulmonary strongyloidiasis. 38
30569952 2018
96
Strongyloidiasis and Culture-Negative Suppurative Meningitis, Japan, 1993-2015. 38
30457540 2018
97
Late post-kidney transplant Strongyloides hyperinfection syndrome. 38
30107075 2018
98
Seroepidemiological aspects of human infection by Strongyloides stercoralis in Alfenas, southern Minas Gerais, Brazil. 38
30517543 2018
99
Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy. 38
30226142 2018
100
High seroprevalence of Strongyloides stercoralis among individuals from endemic areas considered for solid organ transplant donation: A retrospective serum-bank based study. 38
30496174 2018
101
Detection of immune complexes and evaluation of alcoholic individuals' serological profile in the diagnosis of strongyloidiasis. 38
29933043 2018
102
Impact of the health education and preventive equipment package (HEPEP) on prevention of Strongyloides stercoralis infection among rural communities in Northeast Thailand: a cluster randomized controlled trial. 38
30340481 2018
103
[Severe infection by Strongyloides stercoralis in ascitic liquid]. 38
30860511 2018
104
Inducible nitric oxide synthase controls experimental Strongyloides infection. 38
30035318 2018
105
Diagnostic comparison of Baermann funnel, Koga agar plate culture and polymerase chain reaction for detection of human Strongyloides stercoralis infection in Maluku, Indonesia. 38
30074085 2018
106
Hypermetabolic Diffuse Proximal Small Bowel Wall Thickening on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography? Consider Strongyloidiasis among the Differentials. 38
30386068 2018
107
Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease. 38
30425838 2018
108
[Severe Strongyloides stercoralis infection: a case report]. 38
30350521 2018
109
Strongyloides stercoralis: detection of parasite-derived DNA in serum samples obtained from immunosuppressed patients. 38
29978421 2018
110
Central nervous system Strongyloides stercoralis. A case report. 38
30649819 2018
111
Parasite allergens. 38
29588070 2018
112
Global output of research on epidermal parasitic skin diseases from 1967 to 2017. 38
30078380 2018
113
Molecular and Immnune Diagnosis: Further Testing for Human Strongyloidiasis. 38
29934882 2018
114
Is Ivermectin Ineffective for Strongyloidiasis? 38
29788131 2018
115
Pulmonary strongyloidiasis presenting micronodules on chest computed tomography. 38
30233896 2018
116
Human Strongyloidiasis in Hawaii: A Retrospective Review of Enzyme-Linked Immunosorbent Assay Serodiagnostic Testing. 38
29943712 2018
117
Molecular diagnosis of Strongyloides stercoralis among transplant candidates. 38
29679429 2018
118
[A disseminated strongyloidiasis in a non immunocompromised patient]. 38
30113779 2018
119
Periumbilical purpura: dermatoscopic findings in disseminated strongyloidiasis. 38
29740812 2018
120
Evaluation of two prognostic indices for adult T-cell leukemia/lymphoma in the subtropical endemic area, Okinawa, Japan. 38
29772611 2018
121
Immune complex detection in saliva samples: an innovative proposal for the diagnosis of human strongyloidiasis. 38
29239289 2018
122
Strongyloidiasis in humans: diagnostic efficacy of four conventional methods and real-time polymerase chain reaction. 38
30133633 2018
123
Worming Your Way Through the Gastrointestinal Tract: A Case of Strongyloidiasis. 38
29505750 2018
124
Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors. 38
30064407 2018
125
Metaperiodate deglycosylation of Strongyloides venezuelensis larvae: Immunochemical characterization and antigen production for human strongyloidiasis diagnosis. 38
29454735 2018
126
Argument for Inclusion of Strongyloidiasis in the Australian National Notifiable Disease List. 38
30274457 2018
127
Paediatric Strongyloidiasis in Central Australia. 38
30274460 2018
128
Transrenal DNA-based diagnosis of Strongyloides stercoralis (Grassi, 1879) infection: Bayesian latent class modeling of test accuracy. 38
29856738 2018
129
Organ donor screening practices for Strongyloides stercoralis infection among US organ procurement organizations. 38
29512242 2018
130
Treatment of disseminated Strongyloides spp. infection in an infant Sumatran orangutan (Pongo abelii). 38
29493782 2018
131
Disseminated Strongyloidiasis in Association with Nephrotic Syndrome. 38
30197904 2018
132
ELISA based on a recombinant Paragonimus heterotremus protein for serodiagnosis of human paragonimiasis in Thailand. 38
29843786 2018
133
Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo. 38
29774301 2018
134
Parasitic Infections Associated with Unfavourable Outcomes in Transplant Recipients. 38
30344258 2018
135
The Health Effects of Strongyloidiasis on Pregnant Women and Children: A Systematic Literature Review. 38
30274446 2018
136
Strongyloidiasis Outside Endemic Areas: Long-term Parasitological and Clinical Follow-up After Ivermectin Treatment. 38
29360939 2018
137
A Community-Directed Integrated Strongyloides Control Program in Queensland, Australia. 38
30274444 2018
138
The Unique Life Cycle of Strongyloides stercoralis and Implications for Public Health Action. 38
30274449 2018
139
Extended screening for infectious diseases among newly-arrived asylum seekers from Africa and Asia, Verona province, Italy, April 2014 to June 2015. 38
29692316 2018
140
Terminal ileum resection as a trigger for Strongyloides stercoralis hyperinfection and ensuing serial sepsis in a 37-year-old patient with complicated Crohn's disease: a case report. 38
29642251 2018
141
Gastroduodenal involvement in disseminated strongyloidiasis. 38
30483566 2018
142
Identification and Preliminary Evaluation of a Novel Recombinant Protein for Serodiagnosis of Strongyloidiasis. 38
29436335 2018
143
Eosinophilia in Advanced HIV Infection with Hyperinfection Syndrome: A Case Report. 38
29962800 2018
144
Investigations for the Possible Use of a Monoclonal Antibody Produced against Strongyloides ratti Antigen as an Immunodiagnostic Reagent for Active Strongyloidiasis. 38
30069204 2018
145
Severe Strongyloidiasis in Solid Organ Transplant Recipients: Should We Preventively Treat the Recipient, the Donor, or Both? 38
29363441 2018
146
Opportunistic and non-opportunistic intestinal parasites in HIV/ AIDS patients in relation to their clinical and epidemiological status in a specialized medical service in Goiás, Brazil. 38
29538510 2018
147
Management of severe strongyloidiasis attended at reference centers in Spain. 38
29474356 2018
148
Image Gallery: Periumbilical purpura: a dermatological clue for disseminated strongyloidiasis. 38
29441550 2018
149
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America. 38
29381647 2018
150
Schistosomiasis and Strongyloidiasis Recommendations for Solid-Organ Transplant Recipients and Donors. 38
29381575 2018
151
Electroacupuncture in rats infected with Strongyloides venezuelensis: effects on gastrointestinal transit and parasitological measurements. 38
29102965 2018
152
Low incidence of helminth infections (schistosomiasis, strongyloidiasis, filariasis, toxocariasis) among Dutch long-term travelers: A prospective study, 2008-2011. 38
29847574 2018
153
Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America. 38
30532789 2018
154
Newly Arrived African Migrants to Spain: Epidemiology and Burden of Disease. 38
29165212 2018
155
Strongyloides stercoralis infection in a Spanish regional hospital: Not just an imported disease. 38
27743682 2018
156
Chronic strongyloidiasis with recurrent asthma exacerbations and steroid-associated 'hives'. 38
29348277 2018
157
Strongyloides stercoralis hyperinfection in an unconscious diabetic patient with dermatomyositis. 38
29567897 2018
158
Prevalence of and risk factors for malaria, filariasis, and intestinal parasites as single infections or co-infections in different settlements of Gabon, Central Africa. 38
29378644 2018
159
Fatal pancytopenia due to albendazole treatment for strongyloidiasis. 38
29942764 2018
160
Pulmonary strongyloidiasis causing septic shock in a patient with Crohn's disease. 38
29977759 2018
161
Molecular diagnosis of strongyloidiasis in a population of an endemic area through nested-PCR. 38
29564068 2018
162
Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. 38
29985913 2018
163
Parasitological versus molecular diagnosis of strongyloidiasis in serial stool samples: how many? 38
28112060 2018
164
Strongyloidosis Hyperinfection Syndrome in an HIV-Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome. 38
30510823 2018
165
Prevalence and associated risk factors of Strongyloides stercoralis infection in Lower Myanmar. 38
30598622 2018
166
Cross-Cultural, Aboriginal Language, Discovery Education for Health Literacy and Informed Consent in a Remote Aboriginal Community in the Northern Territory, Australia. 38
30274413 2018
167
Chronic intestinal pseudo-obstruction due to Strongyloides stercoralis. 38
30101070 2018
168
High prevalence of S. Stercoralis infection among patients with Chagas disease: A retrospective case-control study. 38
29385128 2018
169
Prevalence and molecular characterization of Strongyloides stercoralis, Giardia duodenalis, Cryptosporidium spp., and Blastocystis spp. isolates in school children in Cubal, Western Angola. 38
29378626 2018
170
A case of adenocarcinoma developed in the small intestine with chronic strongyloidiasis. 38
28988405 2017
171
Avidity as a criterion for diagnosis of human strongyloidiasis increases specificity of IgG ELISA. 38
28969935 2017
172
The severely under-recognized public health risk of strongyloidiasis in North American cities-A One Health approach. 38
28670749 2017
173
Application of PCR-Based Tools to Explore Strongyloides Infection in People in Parts of Northern Australia. 38
30270919 2017
174
Anemia, intractable vomiting, chronic diarrhea, and syndrome of inappropriate antidiuretic secretion: a diagnostic dilemma: Disseminated strongyloidosis in a patient with newly diagnosed HTLV infection-case report and review of literature. 38
29384908 2017
175
Case Report: A Case of Recurrent Strongyloides stercoralis Colitis in a Patient with Multiple Myeloma. 38
29140233 2017
176
Acute strongyloidiasis in a child recently returned from vacation in Cuba. 38
29158455 2017
177
Strongyloides stercoralis seroprevalence in Vietnam. 38
29039287 2017
178
Strongyloides stercoralis infection increases the likelihood to detect Trypanosoma cruzi DNA in peripheral blood in Chagas disease patients. 38
28869694 2017
179
Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987-2013) in the absence of disease-specific control measures. 38
28929562 2017
180
The changing aetiology of eosinophilia in migrants and returning travellers in the Hospital for Tropical Diseases, London 2002-2015: An observational study. 38
28842188 2017
181
Occlusive Nonvasculitic Vasculopathy. 38
27759698 2017
182
Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems. 38
28893741 2017
183
An eleven-year retrospective hospital-based study of epidemiological data regarding human strongyloidiasis in northeast Thailand. 38
28923008 2017
184
Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries. 38
28749768 2017
185
Mass drug administration for the prevention human strongyloidiasis should consider concomitant treatment of dogs. 38
28837662 2017
186
Purpuric lesion in an immunocompromised patient: a presentation of disseminated strongyloidiasis. 38
28261873 2017
187
Strongyloides stercoralis in solid organ transplantation: early diagnosis gets the worm. 38
28562417 2017
188
Different but overlapping populations of Strongyloides stercoralis in dogs and humans-Dogs as a possible source for zoonotic strongyloidiasis. 38
28793306 2017
189
Occurrence of strongyloidiasis in privately owned and sheltered dogs: clinical presentation and treatment outcome. 38
28728589 2017
190
Serological and molecular tests for the diagnosis of Strongyloides stercoralis infection in dogs. 38
28493000 2017
191
Viability of Strongyloides venezuelensis eggs and larvae in vermiculite containing the fungus Duddingtonia flagrans. 38
28508164 2017
192
Spectrum and burden of neglected tropical diseases observed in an infectious and tropical diseases unit in Florence, Italy (2000-2015). 38
28054225 2017
193
Novel Findings in HIV, Immune Reconstitution Disease and Strongyloides stercoralis Infection. 38
28641722 2017
194
Identification of antigenic proteins in Strongyloides stercoralis by proteomic analysis. 38
28455628 2017
195
Screening of immunocompromised patients at risk of strongyloidiasis in western Turkey using ELISA and real-time PCR. 38
28618740 2017
196
Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study. 38
28259548 2017
197
Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases. 38
28464844 2017
198
Disseminated strongyloidiasis and concomitant Aspergillus infection with central nervous system involvement. 38
28139968 2017
199
Cross-reactivity of the 31 kDa antigen of Angiostrongylus cantonensis - Dealing with the immunodiagnosis of meningoencephalitis. 38
27866477 2017
200
[Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection]. 38
28731999 2017
201
Diagnosis of Strongyloides stercoralis by morphological characteristics combine with molecular biological methods. 38
28124134 2017
202
In vitro efficacy of latex and purified papain from Carica papaya against Strongyloides venezuelensis eggs and larvae. 38
28380118 2017
203
Intestinal strongyloidiasis: radiological findings that support the diagnosis. 38
28428660 2017
204
Strongyloidiasis in Latin American immigrants: a pilot study. 38
27121364 2017
205
Strongyloides infection in rodents: immune response and immune regulation. 38
26905057 2017
206
Enterococcal meningitis in association with Strongyloides hyperinfection syndrome. 38
28331839 2017
207
A Strong and Fortuitous Case of Dyspnea. 38
28414672 2017
208
[Clinical and epidemiological characteristics of strongyloidiasis in patients with comorbidities]. 38
28394981 2017
209
Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens. 38
27894367 2017
210
Gastric Strongyloidiasis: Report of 2 Cases and Brief Review of the Literature. 38
27965275 2017
211
Unexpected hosts: imaging parasitic diseases. 38
27882478 2017
212
The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial. 38
28178298 2017
213
Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemia. 38
27860061 2017
214
Strongyloidiasis Current Status with Emphasis in Diagnosis and Drug Research. 38
28210503 2017
215
Colorectal Cancer Associated with Strongyloides stercoralis Colitis. 38
28879209 2017
216
Screening for parasite infections in immigrant children from low-income countries. 38
27156246 2017
217
Twenty-five Years of Chronic Strongyloidiasis in an Immigrant. 38
28469498 2017
218
Linear and urticarial rash-like manifestation of acute strongyloidiasis. 38
27613704 2017
219
A Case of Bacteremia and Meningitis Associated with Piperacillin-Tazobactam Nonsusceptible, Ceftriaxone Susceptible Escherichia coli during Strongyloides Hyperinfection in an Immunocompromised Host. 38
29359054 2017
220
A Case of Strongyloidiasis: An Immigrant Healthcare Worker Presenting with Fatigue and Weight Loss. 38
28744381 2017
221
Biliary Strongyloides stercoralis With Cholecystitis and Extensive Portal Vein Thrombosis. 38
29181423 2017
222
Case report of a computerized tomography sign in Strongyloides stercoralis infection. 38
28721104 2017
223
[Strongyloidiasis native to Asturias]. 38
27151772 2017
224
Strongyloidiasis-Related IRIS. 38
27733639 2017
225
Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 Cells. 38
28676845 2017
226
Surveillance of strongyloidiasis in Spanish in-patients (1998-2014). 38
29284005 2017
227
Importance of a Rapid and Accurate Diagnosis in Strongyloides Stercoralis and Human T-Lymphotropic Virus 1 Co-infection: A Case Report and Review of the Literature. 38
29270152 2017
228
Strongyloidiasis Presenting as Epigastric Pain. 38
27924100 2016
229
The Lack of Association of Eosinophilia and Neurocysticercosis at Clinical Presentation: A Retrospective Analysis of Cases Seen at the National Institutes of Health, 1985-2015. 38
27928090 2016
230
Strongyloides hyper infection in a steroid dependent leprosy patient. 38
30226358 2016
231
LIMIT OF MOLECULAR DETECTION OF STRONGYLOIDES STERCORALIS PARASITE PERFORMING.TWO PCR PROTOCOLS. 38
30230751 2016
232
Severe Anemia and Lung Nodule in an Immunocompetent Adopted Girl with Strongyloides stercoralis Infection. 38
27601521 2016
233
Pulmonary strongyloidiasis and hyperinfection in a renal transplant patient. 38
27891008 2016
234
Strongyloidiasis in Ontario: Performance of diagnostic tests over a 14-month period. 38
27794473 2016
235
Epidemiological Characteristics of Strongyloidiasis in Inhabitants of Indigenous Communities in Borneo Island, Malaysia. 38
27853126 2016
236
Strongyloides stercoralis diagnostic polypeptides for human strongyloidiasis and their proteomic analysis. 38
27312043 2016
237
[Strongyloidiasis as cause of lower gastrointestinal bleeding]. 38
28112346 2016
238
Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort. 38
27329124 2016
239
Effect of ivermectin on allergy-type manifestations in occult strongyloidiasis. 38
27566864 2016
240
Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment. 38
27527631 2016
241
[Pulmonary strongyloidiasis]. 38
28112345 2016
242
Pulmonary Strongyloidiasis Masquerading as Exacerbation of Chronic Obstructive Pulmonary Disease. 38
27790284 2016
243
Persistent infectious and tropical diseases in immigrant correctional populations. 38
27637104 2016
244
Prevalence of Strongyloides stercoralis and Other Intestinal Parasites among Institutionalized Mentally Disabled Individuals in Rasht, Northern Iran. 38
28127364 2016
245
The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community. 38
27681971 2016
246
Donor-derived Strongyloides stercoralis hyperinfection syndrome after simultaneous kidney/pancreas transplantation. 38
27590562 2016
247
The alkylphospholipid edelfosine shows activity against Strongyloides venezuelensis and induces apoptosis-like cell death. 38
27394030 2016
248
Seroprevalence of fascioliasis, toxocariasis, strongyloidiasis and cysticercosis in blood samples diagnosed in Medic Medical Center Laboratory, Ho Chi Minh City, Vietnam in 2012. 38
27595647 2016
249
Acute strongyloidiasis in a traveller returning from South East Asia. 38
27192701 2016
250
Advocating for both Environmental and Clinical Approaches to Control Human Strongyloidiasis. 38
27706031 2016
251
Donor-Derived Strongyloidiasis Infection in Solid Organ Transplant Recipients: A Review and Pooled Analysis. 38
27742318 2016
252
StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control. 38
27607192 2016
253
DIAGNOSIS OF Strongyloides stercoralis INFECTION IN IMMUNOCOMPROMISED PATIENTS BY SEROLOGICAL AND MOLECULAR METHODS. 38
27680168 2016
254
Seroepidemiology of Strongyloides stercoralis amongst immunocompromised patients in Southwest Iran. 38
29988178 2016
255
Poorly controlled asthma and strongyloidiasis in a nonendemic area of the United States. 38
27298264 2016
256
Comparative Diagnosis of Strongyloidiasis in Immunocompromised Patients. 38
27296387 2016
257
IBD or strongyloidiasis? 38
26634698 2016
258
Parasites. 38
27726821 2016
259
Serodiagnosis of fasciolosis by fast protein liquid chromatography-fractionated excretory/secretory antigens. 38
27130320 2016
260
The role of IL-33/ST2, IL-4, and eosinophils on the airway hyperresponsiveness induced by Strongyloides venezuelensis in BALB/c mice. 38
27102638 2016
261
Economic Analysis of the Impact of Overseas and Domestic Treatment and Screening Options for Intestinal Helminth Infection among US-Bound Refugees from Asia. 38
27509077 2016
262
First molecular identification and report of genetic diversity of Strongyloides stercoralis, a current major soil-transmitted helminth in humans from Lao People's Democratic Republic. 38
27083185 2016
263
Epidemiology of Strongyloides stercoralis in northern Italy: results of a multicentre case-control study, February 2013 to July 2014. 38
27525375 2016
264
Disseminated Strongyloidiasis in an Immunodeficient Patient (Pemphigus Vulgaris) Due to Corticosteroid Therapy: A Case Report. 38
28127349 2016
265
Strongyloides stercoralis infection in patients with systemic lupus erythematosus: diagnosis and prevention of severe strongyloidiasis. 38
26258603 2016
266
Cutaneous Strongyloides Infection Postchemotherapy. 38
26896181 2016
267
Diagnosis of the strongyloid nematode Strongyloides venezuelensis in experimentally infected rats. 38
26169305 2016
268
Strong-LAMP: A LAMP Assay for Strongyloides spp. Detection in Stool and Urine Samples. Towards the Diagnosis of Human Strongyloidiasis Starting from a Rodent Model. 38
27415764 2016
269
Notes from the Field: Strongyloidiasis at a Long-Term-Care Facility for the Developmentally Disabled - Arizona, 2015. 38
27310213 2016
270
Comparison between the effect of Lawsonia inermis and flubendazole on Strongyloides species using scanning electron microscopy. 38
27413314 2016
271
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. 38
27353595 2016
272
Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population. 38
27011343 2016
273
Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. 38
27432907 2016
274
Strongyloidiasis: A Disease of Socioeconomic Disadvantage. 38
27213420 2016
275
Specific IgG and immune complex responses to parthenogenetic females and eggs of nematode Strongyloides venezuelensis for the diagnosis of immunosuppression in infected rats. 38
25997825 2016
276
Comparison between PCR and larvae visualization methods for diagnosis of Strongyloides stercoralis out of endemic area: A proposed algorithm. 38
26868702 2016
277
A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review. 38
27175679 2016
278
Short epitope-based synthetic peptides for serodiagnosis of human strongyloidiasis. 38
26956434 2016
279
Disseminated Strongyloidiasis in an Iranian Immunocompromised Patient: A Case Report. 38
28096866 2016
280
Infectious Diseases in Sub-Saharan Immigrants to Spain. 38
26880782 2016
281
[Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use]. 38
26654554 2016
282
Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients. 38
27115603 2016
283
Real-Time Polymerase Chain Reaction in Stool Detects Transmission of Strongyloides stercoralis from an Infected Donor to Solid Organ Transplant Recipients. 38
26880781 2016
284
Chronic spontaneous urticaria and internal parasites--a systematic review. 38
26648083 2016
285
Unsuspected Strongyloides stercoralis infection in hospital patients with comorbidity in need of proper management. 38
26923091 2016
286
Severe strongyloidiasis in AIDS: relative risk obscured by absolute rarity. 38
26825034 2016
287
Association between Strongyloides stercoralis infection and cortisol secretion in alcoholic patients. 38
26592319 2016
288
Parasitic Infections in Hematopoietic Stem Cell Transplantation. 38
27413527 2016
289
Strongyloides stercoralis Infection in Alcoholic Patients. 38
28105424 2016
290
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. 38
26778150 2016
291
Protein Loosing Enteropathy Secondary to Strongyloidiasis: Case Report and Review of the Literature. 38
26881152 2016
292
CATMAT statement on disseminated strongyloidiasis: Prevention, assessment and management guidelines. 38
29769976 2016
293
Chronic strongyloidiasis - Don't look and you won't find. 38
27051986 2016
294
Strongyloidiasis in the immunocompetent: an overlooked infection. 38
27609726 2016
295
Strongyloidiasis in a young French woman raises concern about possible ongoing autochthonous transmission in Spain. 38
26617257 2016
296
Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States. 38
26925367 2016
297
Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literature. 38
26462990 2016
298
Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection. 38
27703835 2016
299
Strongyloidiasis in immigrants and refugees in Canada. 38
26149698 2015
300
Mucocutaneous manifestations of helminth infections: Nematodes. 38
26568337 2015
301
Mucocutaneous manifestations of helminth infections: Trematodes and cestodes. 38
26568338 2015
302
Treatment with nitric oxide donors diminishes hyperinfection by Strongyloides venezuelensis in mice treated with dexamethasone. 38
26342794 2015
303
Comparison of parasitological, immunological and molecular methods for evaluation of fecal samples of immunosuppressed rats experimentally infected with Strongyloides venezuelensis. 38
26442899 2015
304
Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador. 38
26540412 2015
305
Clinical Image In Gastroenterology: Disseminated gastrointestinal strongyloidiasis. 38
26481977 2015
306
[A LOCAL CASE OF CHRONIC STRONGYLOIDIASIS IN THE VOLGOGRAD REGION]. 38
26827587 2015
307
Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome. 38
24902477 2015
308
Immunoblotting using Strongyloides venezuelensis larvae, parthenogenetic females or eggs extracts for the diagnosis of experimentally infected immunosuppressed rats. 38
26219202 2015
309
Detection of parasite-specific IgG and IgA in paired serum and saliva samples for diagnosis of human strongyloidiasis in northern Paraná state, Brazil. 38
26238982 2015
310
IMMUNODIAGNOSIS OF HUMAN STRONGYLOIDIASIS: USE OF SIX DIFFERENT ANTIGENIC FRACTIONS FROM Strongyloides venezuelensis PARASITIC FEMALES. 38
26603231 2015
311
Strongyloides stercoralis hyperinfection causing eosinophilic ascites. 38
26097138 2015
312
Parasite Antigen-Specific Regulation of Th1, Th2, and Th17 Responses in Strongyloides stercoralis Infection. 38
26202988 2015
313
Immunofluorescence assay for diagnosis of strongyloidiasis in immunocompromised patients. 38
25832456 2015
314
Infectious Risks of Traveling Abroad. 38
26350325 2015
315
Strongyloides stercoralis hyperinfection: an unusual cause of gastrointestinal bleeding. 38
26466210 2015
316
High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease. 38
26143070 2015
317
Chronic Larva Currens Following Tourist Travel to the Gambia and Southeast Asia Over 20 Years Ago. 38
25775620 2015
318
Cervical strongyloidiasis in an immunocompetent patient: A clinical surprise. 38
26275275 2015
319
A Fatal Case of Strongyloidiasis in Pregnancy. 38
25774935 2015
320
Uncommon presentation of Strongyloidiasis: chronic malabsorption, multiple small bowel strictures and appendicitis in HTLV-1 positive patient. 38
27522750 2015
321
Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis. 38
25877389 2015
322
Serological study of Trypanosoma cruzi, Strongyloides stercoralis, HIV, human T cell lymphotropic virus (HTLV) and syphilis infections in asymptomatic Latin-American immigrants in Spain. 38
26065661 2015
323
Strongyloidiasis: a case for notification in Australia? 38
26021359 2015
324
Parasitic colitis. 38
26034403 2015
325
Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy. 38
25846292 2015
326
Novel approaches to the diagnosis of Strongyloides stercoralis infection. 38
25887711 2015
327
Clinical conditions associated with intestinal strongyloidiasis in Rio de Janeiro, Brazil. 38
26108011 2015
328
Structural and functional characterization of a novel scFv anti-HSP60 of Strongyloides sp. 38
25994608 2015
329
Donor-derived Strongyloides stercoralis infection in solid organ transplant recipients in the United States, 2009-2013. 38
25703251 2015
330
[Strongyloidiasis: who is at risk of severe infection and how to prevent it?]. 38
26050304 2015
331
Strongyloidiasis with emphasis on human infections and its different clinical forms. 38
25911368 2015
332
Development of Ss-NIE-1 recombinant antigen based assays for immunodiagnosis of strongyloidiasis. 38
25860665 2015
333
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy. 38
25925183 2015
334
Molecular diagnosis of strongyloidiasis in tropical areas: a comparison of conventional and real-time polymerase chain reaction with parasitological methods. 38
25946255 2015
335
Strongyloidiasis: an unusual cause of septic shock with pneumonia and enteropathy in western countries. 38
25819827 2015
336
[Strongyloidiasis in nephrologic patients]. 38
26005937 2015
337
Five cases of recurrent meningitis associated with chronic strongyloidiasis. 38
25548379 2015
338
Strongyloidiasis: a case with acute pancreatitis and a literature review. 38
25805946 2015
339
Bacteroides-associated pylephlebitis in a patient with strongyloidiasis. 38
25510718 2015
340
Is strongyloidiasis endemic in Spain? 38
25654324 2015
341
Severe strongyloidiasis with negative serology after corticosteroid treatment. 38
25690926 2015
342
Strongyloidiasis in a healthy 8-year-old girl in north-eastern USA. 38
25022873 2015
343
Prevalence of strongyloidiasis in Latin America: a systematic review of the literature. 38
24990510 2015
344
Application of real-time PCR for the detection of Strongyloides spp. in clinical samples in a reference center in Spain. 38
25447829 2015
345
Comorbid gastric adenocarcinoma and gastric and duodenal Strongyloides stercoralis infection: a case report. 38
25748714 2015
346
Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection. 38
25668740 2015
347
Membrane fractions from Strongyloides venezuelensis in the immunodiagnosis of human strongyloidiasis. 38
25651330 2015
348
African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases. 38
26401658 2015
349
Screening for Schistosoma mansoni and Strongyloides stercoralis Infection Among Brazilian Immigrants in the United States. 38
26034754 2015
350
A COMPLICATED CASE OF STRONGYLOIDIASIS PRESENTING WITH INTESTINAL LYMPHADENOPATHY OBSTRUCTION: MOLECULAR IDENTIFICATION. 38
26513898 2015
351
Pulmonary Hemorrhage Secondary to Disseminated Strongyloidiasis in a Patient with Systemic Lupus Erythematosus. 38
26101672 2015
352
Gastrointestinal strongyloidiasis. 38
26062140 2015
353
Megaduodenum associated with gastric strongyloidiasis. 38
25951613 2015
354
Strongyloidiasis in immigrants in Southern Spain. 38
25205127 2015
355
Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report. 38
25904959 2015
356
Parasitic infections in travelers and immigrants: part II helminths and ectoparasites. 38
25598339 2015
357
[Weight loss and chronic diarrhea in a 54-year-old man with HIV infection]. 38
25583311 2015
358
Enterobiasis and strongyloidiasis and associated co-infections and morbidity markers in infants, preschool- and school-aged children from rural coastal Tanzania: a cross-sectional study. 38
25486986 2014
359
The detergent fraction is effective in the detection of IgG anti-Strongyloides stercoralis in serum samples from immunocompromised individuals. 38
25091831 2014
360
Strongyloides stercoralis infection in marmosets: replication of complicated and uncomplicated human disease and parasite biology. 38
25499310 2014
361
Strongyloides stercoralis and relatives: recent advances in general and molecular biology. 38
29577012 2014
362
Management of Strongyloides stercoralis: a puzzling parasite. 38
25173343 2014
363
[Fatal strongyloidiasis following corticosteroid therapy]. 38
25065661 2014
364
Gastroscopic findings of Strongyloidiasis causing unresolved upper gastrointestinal bleeding. 38
26349175 2014
365
A patient with disseminated strongyloidiasis with erythroderma in a nonendemic area. 38
24720636 2014
366
Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus. 38
25092815 2014
367
Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE. 38
25051188 2014
368
[Diagnosis of Strongyloides Stercoralis infection: meta-analysis on evaluation of conventional parasitological methods (1980-2013)]. 38
25327268 2014
369
Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communities. 38
25254655 2014
370
Development of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based biosensor technology. 38
25102174 2014
371
Strongyloidiasis--an insight into its global prevalence and management. 38
25121962 2014
372
Hyperinfection strongyloidiasis in renal transplant recipients. 38
25150235 2014
373
Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature. 38
24890466 2014
374
Update on immunologic and molecular diagnosis of human strongyloidiasis. 38
24686097 2014
375
Relevance of eosinophilia and hyper-IgE in immigrant children. 38
25058145 2014
376
A case report of strongyloidiasis associated with giardiasis in a patient with renal calculi from a tertiary care center in South India. 38
25191059 2014
377
Pulmonary strongyloidiasis following renal transplantation without travel to an endemic area. 38
25988037 2014
378
Detection of Strongyloides stercoralis infection among cancer patients in a major hospital in Kelantan, Malaysia. 38
25091885 2014
379
[Intestinal strongyloidiasis in a psoriasis patient with diabetes]. 38
25016122 2014
380
High prevalence and spatial distribution of Strongyloides stercoralis in rural Cambodia. 38
24921627 2014
381
An unsuspected cause of diarrhoea and gastrointestinal bleeding during corticosteroid therapy. 38
25090826 2014
382
Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature. 38
24612907 2014
383
Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia. 38
24615124 2014
384
Aetiologies of creeping eruption: 78 cases. 38
24116380 2014
385
Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis. 38
24648484 2014
386
Conventional PCR for molecular diagnosis of human strongyloidiasis. 38
24476900 2014
387
[Persistent tropical diseases among migrants]. 38
24791430 2014
388
A review of mortality from parasitic and vector-borne diseases in the U.S. Air Force from 1970 to 2012. 38
24224859 2014
389
Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. 38
24655358 2014
390
Parasitic infections based on 320 clinical samples submitted to Hanyang University, Korea (2004-2011). 38
24850969 2014
391
Prevalence and risk factors of acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in Thailand. 38
24766337 2014
392
An Analysis of Clinical Characteristics of Strongyloides stercoralis in 70 indigenous patients in Iran. 38
25848380 2014
393
Global progress towards eliminating gastrointestinal helminth infections. 38
24241244 2014
394
Enteric infections. 38
24706227 2014
395
PCR for the diagnosis of abdominal angiostrongyliasis in formalin-fixed paraffin-embedded human tissue. 38
24705328 2014
396
Strongyloidiasis and diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus. 38
25024706 2014
397
Association between footwear use and neglected tropical diseases: a systematic review and meta-analysis. 38
25393620 2014
398
Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population. 38
24454973 2014
399
Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011. 38
25009682 2014
400
Imported strongyloidiasis in Spain. 38
24211226 2014
401
Bacteriophage-fused peptides for serodiagnosis of human strongyloidiasis. 38
24874206 2014
402
Autochthonous strongyloidiasis, Bordeaux area, South-Western France. 38
23433632 2014
403
Whats new in global infectious diseases? Strongyloidiasis and syndrome of inappropriate antidiuretic hormone secretion (SIADH). 38
24741222 2014
404
Images of the month: A case of strongyloidiasis presenting as a colonic mass. 38
24402527 2014
405
Strongyloidiasis: the cause of multiple gastrointestinal ulcers in an immunocompetent individual. 38
24648845 2014
406
Modified formalin-ether concentration technique for diagnosis of human strongyloidiasis. 38
24516283 2013
407
Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010. 38
23761268 2013
408
Pulmonary hydatidosis, strongyloidiasis and paragonimiasis in India. 38
24968568 2013
409
Strongyloidiasis complicating immunosuppression for pemphigus vulgaris. 38
23855642 2013
410
Physicochemical properties of the modeled structure of astacin metalloprotease moulting enzyme NAS-36 and mapping the druggable allosteric space of Heamonchus contortus, Brugia malayi and Ceanorhabditis elegans via molecular dynamics simulation. 38
24402824 2013
411
Determinants of reactivation of inapparent Strongyloides stercoralis infection in patients hospitalized for unrelated admitting diagnosis. 38
24081104 2013
412
Increased susceptibility to Strongyloides venezuelensis infection is related to the parasite load and absence of major histocompatibility complex (MHC) class II molecules. 38
24036323 2013
413
[Report of a case of strongyloidiasis with a coinfection by HTLV-1 and onychomycosis]. 38
24419034 2013
414
Notes from the field: Strongyloidiasis in a rural setting--Southeastern Kentucky, 2013. 38
24153316 2013
415
Co-morbid infections in Hansen's disease patients in the United States: considerations for treatment. 38
23980128 2013
416
Seroprevalence of Schistosomiasis and Strongyloides infection in HIV-infected patients from endemic areas attending a European infectious diseases clinic. 38
24010677 2013
417
Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor. 38
23919410 2013
418
Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels. 38
23843560 2013
419
Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis. 38
23740923 2013
420
"Surprise" in the evolution of chronic membranoproliferative glomerulonephritis associated with severe strongyloidiasis under corticotherapy: "hygienic paradox"? 38
23826871 2013
421
Strongyloidiasis--a forerunner of adult T-cell lymphoma. 38
24851529 2013
422
Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain. 38
23509119 2013
423
Review of patients with Strongyloides stercoralis infestation in a tertiary teaching hospital, Kelantan. 38
23817397 2013
424
Laboratory detection of strongyloidiasis: IgG-, IgG4 - and IgE-ELISAs and cross-reactivity with lymphatic filariasis. 38
23448095 2013
425
[Glucocorticoids and... infections, doping, surgery, sexuality]. 38
23415059 2013
426
The role of B-cells in immunity against adult Strongyloides venezuelensis. 38
23705584 2013
427
Strongyloides stercoralis is a cause of abdominal pain, diarrhea and urticaria in rural Cambodia. 38
23688049 2013
428
Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. 38
23223602 2013
429
Cutaneous strongyloidiasis: direct finding of worms on skin potassium hydroxide examination. 38
23039845 2013
430
Late diagnosis of central nervous system involvement associated with lethal dissemination of Strongyloides stercoralis in an advanced HIV patient from Nigeria. 38
23414737 2013
431
Transmission of Strongyloides stercoralis through transplantation of solid organs--Pennsylvania, 2012. 38
23575239 2013
432
Chasing Eosinophilia in Loeffler's Syndrome: A Case of Strongyloidiasis in Upstate New York. 38
23626967 2013
433
[High risk of strongyloïdes hyperinfection in a patient with sarcoidosis]. 38
23587590 2013
434
Strongyloidiasis: an emerging infectious disease in China. 38
23468357 2013
435
Parasitological and molecular diagnosis in experimental Strongyloides venezuelensis infection. 38
23563772 2013
436
Occurrence of strongyloidiasis among patients with HTLV-1/2 seen at the outpatient clinic of the Núcleo de Medicina Tropical, Belém, State of Pará, Brazil. 38
23740053 2013
437
Severe strongyloidiasis: a systematic review of case reports. 38
23394259 2013
438
Strongyloidiasis in a nonagenarian who previously worked in conservancy services. 38
23378359 2013
439
Fatal strongyloidiasis in an immunocompromised HTLV-I infected patient. 38
23108609 2013
440
Strongyloides stercoralis in bronchoalveolar lavage specimen processed as Prussian Blue Stain. 38
21964988 2013
441
Mannose-binding lectin deficiency in a patient with multiple opportunistic infections, strongyloidiasis, and spindle cell tumor. 38
23352534 2013
442
Transcriptomic analysis of four developmental stages of Strongyloides venezuelensis. 38
23022620 2013
443
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. 38
23592987 2013
444
Non-communicable diseases, infection and survival in a retrospective cohort of Indigenous and non-Indigenous adults in central Australia. 38
23872293 2013
445
Strongyloides stercoralis infection in transplanted patients. 38
23826469 2013
446
[Strongyloides stercoralis in a patient with ankylosing spondylitis: case report]. 38
23955914 2013
447
Strongyloides stercoralis: highlighting an imported case of the neglected parasite. 38
23512515 2013
448
Pathology of CNS parasitic infections. 38
23829901 2013
449
[Circumstances for diagnosis and treatment of intestinal parasitosis in France]. 38
23266344 2013
450
Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. 38
23383349 2013
451
The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. 38
23350004 2013
452
Ion-exchange protocol to obtain antigenic fractions with potential for serodiagnosis of strongyloidiasis. 38
22931968 2013
453
Strongyloides stercoralis infection complicating the central nervous system. 38
23829913 2013
454
Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report. 38
23443625 2013
455
Eosinophilia: A poor predictor of Strongyloides infection in refugees. 38
24421809 2013
456
A case of Strongyloides hyperinfection associated with tuberculosis. 38
25705401 2013
457
Identification of a bacteria-like ferrochelatase in Strongyloides venezuelensis, an animal parasitic nematode. 38
23516484 2013
458
E. coli Meningitis Presenting in a Patient with Disseminated Strongyloides stercoralis. 38
24324900 2013
459
Fatal strongyloides hyperinfection complicating a gram-negative sepsis after allogeneic stem cell transplantation: a case report and review of the literature. 38
23936693 2013
460
Detrimental effect of water submersion of stools on development of Strongyloides stercoralis. 38
24358173 2013
461
A rare cause of severe recurrent abdominal pain. 38
23627200 2013
462
Simultaneous Larva Migrans and Larva Currens Caused by Strongyloides stercoralis: A Case Report. 38
23476820 2013
463
Fulminant gastrointestinal hemorrhage due to Strongyloides stercoralis hyperinfection in an AIDS patient. 38
23563839 2013
464
A fatal case of strongyloidiasis stercoralis superinfection in an immunocompromized patient. 38
23469642 2012
465
Expatriates ill after travel: results from the Geosentinel Surveillance Network. 38
23273048 2012
466
Strongyloidiasis in a high risk community of Dhaka, Bangladesh. 38
23084030 2012
467
Marked eosinophilia due to intestinal strongyloidiasis in an immunocompetent patient. 38
23292062 2012
468
[A case of steroid-induced hyperinfective strongyloidiasis with bacterial meningitis]. 38
23172283 2012
469
Strongyloidiasis presenting as larva currens 38 years after presumed exposure. 38
23149200 2012
470
A novel approach based on antigen, antibody and immune complex detection in bronchoalveolar lavage fluid samples from rats experimentally infected with Strongyloides venezuelensis. 38
22897871 2012
471
Hyperinfection with Strongyloides stercoralis. 38
23203176 2012
472
Fatal disseminated strongyloidiasis after kidney transplantation. 38
23152354 2012
473
Spectrum of malabsorption syndrome among adults & factors differentiating celiac disease & tropical malabsorption. 38
23041739 2012
474
Production and evaluation of Toxoplasma gondii recombinant GRA7 for serodiagnosis of human infections. 38
22949752 2012
475
Symptomatic chronic strongyloidiasis in children following treatment for solid organ malignancies: case reports and literature review. 38
23018511 2012
476
Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin. 38
22975175 2012
477
Dexamethasone reduces bronchial wall remodeling during pulmonary migration of Strongyloides venezuelensis larvae in rats. 38
22808527 2012
478
Seroepidemiology of Strongyloides stercoralis in Dhaka, Bangladesh. 38
22813776 2012
479
Prevalence of Strongyloides stercoralis in an urban US AIDS cohort. 38
23265425 2012
480
Strongyloides stercoralis infection: a health issue regarding indigenous people in Taiwan. 38
22647849 2012
481
Endoscopic and imaging findings in protein-losing enteropathy. 38
22138845 2012
482
Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. 38
22691685 2012
483
Strongyloidiasis: a diagnosis more common than we think. 38
22555259 2012
484
[High prevalence of strongyloidiasis among immigrants]. 38
23387007 2012
485
Callithrix penicillata as a nonhuman primate model for strongyloidiasis. 38
22388422 2012
486
Bilateral parotid abscesses as the initial presentation of strongyloidiasis in the immunocompetent host. 38
21384459 2012
487
Hyperinfection of Strongyloides stercoralis in an immunocompetent patient. 38
23767024 2012
488
Imported strongyloidiasis: epidemiology, presentations, and treatment. 38
22322601 2012
489
Incidence rate and causes of infection in Thai systemic sclerosis patients. 38
22709489 2012
490
HTLV infection and strongyloidal hyperinfection syndrome. 38
23409425 2012
491
Use of larval, parasitic female and egg antigens from Strongyloides venezuelensis to detect parasite-specific IgG and immune complexes in immunodiagnosis of human strongyloidiasis. 38
22309625 2012
492
Ivermectin in human medicine, an overview of the current status of its clinical applications. 38
22039800 2012
493
Rare Case of Strongyloides stercoralis Hyperinfection in a Greek Patient with Chronic Eosinophilia. 38
22708034 2012
494
Strongyloides, dengue fever, and tuberculosis conversions in New Zealand police deploying overseas. 38
22530825 2012
495
A series on intestinal strongyloidiasis in immunocompetent and immunocompromised hosts. 38
23025061 2012
496
[Preparation of a prototype of the anthelmintic mitranox (MCT-31) and evaluation of its therapeutic efficacy in sheep moniesiosis and strongyloidiasis]. 38
22774511 2012
497
Characterization of a secreted macrophage migration inhibitory factor homologue of the parasitic nematode Strongyloides acting at the parasite-host cell interface. 38
22037391 2012
498
Antigen, antibody and immune complex detection in serum samples from rats experimentally infected with Strongyloides venezuelensis. 38
22306281 2012
499
[Persistent Eosinophilia--differential diagnosis and work-up]. 38
22454311 2012
500
Radiological appearance of small bowel in severe strongyloidiasis. 38
22370850 2012
501
Prevalence of Strongyloides stercoralis and other intestinal parasitic infections among mentally retarded residents in central institution of southern Iran. 38
23569874 2012
502
Strongyloidiasis: an emerging infectious disease that simulates allergic diseases. 38
22812198 2012
503
Gastric strongyloidiasis as multiple small gastric nodules. 38
23569473 2012
504
Republished research: Helminths: an unrecognised disease burden prevalent among migrants in the gastroenterology clinic. 38
22187490 2012
505
Strongyloides hyperinfection syndrome complications: a case report and review of the literature. 38
25134190 2012
506
Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic. 38
23450241 2012
507
Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy. 38
22924046 2012
508
Neglected tropical diseases: diagnosis, clinical management, treatment and control. 38
23180107 2012
509
Vaccination with Strongyloides ratti heat shock protein 60 increases susceptibility to challenge infection by induction of Th1 response. 38
22172506 2012
510
The transcriptome analysis of Strongyloides stercoralis L3i larvae reveals targets for intervention in a neglected disease. 38
22389732 2012
511
Survival in a case of diffuse alveolar hemorrhage due to Strongyloides stercoralis hyperinfection. 38
26029582 2012
512
Specific IgG and IgA to larvae, parthenogenetic females, and eggs of Strongyloides venezuelensis in the immunodiagnosis of human strongyloidiasis. 38
22015324 2012
513
Possible Strongyloides stercoralis infection diagnosed by videocapsule endoscopy in an immunocompetent patient with devastating diarrhea. 38
24713813 2012
514
Strongyloides stercoralis age-1: a potential regulator of infective larval development in a parasitic nematode. 38
22701676 2012
515
Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges. 38
22310820 2011
516
Acute Lymphoblastic Leukemia with Eosinophilia and Strongyloides stercoralis Hyperinfection. 38
23056848 2011
517
Disseminated strongyloidiasis in a immunocompromised host. 38
22253157 2011
518
Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model. 38
22101674 2011
519
Efficacy of parasitological methods for the diagnosis of Strongyloides stercoralis and hookworm in faecal specimens. 38
21896267 2011
520
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 38
22325821 2011
521
Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice. 38
21856350 2011
522
Epidemiological aspects of strongyloidiasis in Brazil. 38
21810305 2011
523
IgG avidity in differential serodiagnosis of human strongyloidiasis active infection. 38
21699917 2011
524
Field survey for strongyloidiasis in eastern Uganda with observations on efficacy of preventive chemotherapy and co-occurrence of soil-transmitted helminthiasis/intestinal schistosomiasis. 38
20961473 2011
525
A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. 38
20430004 2011
526
Prevalence and epidemiology of intestinal parasitism, as revealed by three distinct techniques in an endemic area in the Brazilian Amazon. 38
22117850 2011
527
Impact of global health residency training on medical knowledge of immigrant health. 38
21896795 2011
528
[Combined infection with HTLV-1 and Strongyloides stercoralis]. 38
21800110 2011
529
Diagnosis, clinical features, and self-reported morbidity of Strongyloides stercoralis and hookworm infection in a Co-endemic setting. 38
21886853 2011
530
Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1. 38
21704987 2011
531
Sytemic strongyloidiasis and primary aspergillosis of digestive tract in a patient with T-cell acute lymphoblastic leukemia. 38
21440299 2011
532
Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients. 38
21785992 2011
533
Gastrointestinal strongyloidiasis in immunocompromised patients: a case report. 38
21979285 2011
534
Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. 38
21814588 2011
535
Concurrent infection of candidiasis and strongyloidiasis in an endoscopic biopsy in an immunocompetent host. 38
21934251 2011
536
Comment about nephrotic syndrome in association with strongyloidiasis. 38
21468622 2011
537
Strongyloidiasis presenting as eosinophilic ascites. 38
21871171 2011
538
[Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients]. 38
21879146 2011
539
Molecular Diagnosis of Strongyloides stercoralis Infection by PCR Detection of Specific DNA in Human Stool Samples. 38
22347284 2011
540
[Chronic Strongyloides stercoralis infection. Larva currens as skin manifestation]. 38
20963378 2011
541
Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient. 38
21675505 2011
542
Strongyloidiasis in man 75 years after initial exposure. 38
21529417 2011
543
Donor-derived Strongyloides stercoralis infections in renal transplant recipients. 38
21358367 2011
544
Disseminated paracoccidioidomycosis (simulating metastatic lung cancer) and Strongyloides stercoralis hyperinfestation in a steroid-treated patient. 38
21430109 2011
545
Usefulness of concanavalin-A non-binding fraction of Strongyloides venezuelensis larvae to detect IgG and IgA in human strongyloidiasis. 38
21513846 2011
546
Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. 38
21572981 2011
547
Pulmonary strongyloidiasis associated CD3+ large granular lymphocytosis. 38
21572700 2011
548
Travel-related schistosomiasis, strongyloidiasis, filariasis, and toxocariasis: the risk of infection and the diagnostic relevance of blood eosinophilia. 38
21466667 2011
549
High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. 38
21532747 2011
550
Helminths: an unrecognised disease burden prevalent among migrants in the gastroenterology clinic. 38
28839594 2011
551
Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus foliaceus treatment with mycophenolate mofetil. 38
21455554 2011
552
[Preparation of a prototype of the anthelmintic nadinate (MCT-02) and evaluation of its therapeutic efficacy in sheep moniesiosis and strongyloidiasis]. 38
21797067 2011
553
Risk factors for acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in south India. 38
21654109 2011
554
Novel real-time PCR for the universal detection of Strongyloides species. 38
21163829 2011
555
Strongyloidiasis: a multifaceted disease. 38
21528049 2011
556
Acute strongyloidiasis: a rarity. Chronic strongyloidiasis: a time bomb! 38
21366788 2011
557
Acute strongyloidiasis in Italian tourists returning from Southeast Asia. 38
21366799 2011
558
Update on strongyloidiasis in the immunocompromised host. 38
21308453 2011
559
Migratory route of Strongyloides venezuelensis in Lewis rats: comparison of histological analyses and PCR. 38
20801116 2011
560
A coproantigen diagnostic test for Strongyloides infection. 38
21347447 2011
561
Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. 38
20525017 2011
562
An autopsy case of disseminated strongyloidiasis combined with cytomegalovirus infection. 38
21519131 2011
563
Strongyloidiasis in Assam, India: A community-based study. 38
23508997 2011
564
Colonoscopic findings and pathologic characteristics of Strongyloides colitis: a case series. 38
21266818 2011
565
Epidemiological and clinical picture of parasitic infections in the group of children and adolescents from north-east region of Poland. 38
22165741 2011
566
Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient. 38
21119560 2011
567
Strongyloides stercoralis hyperinfection in a post-renal transplant patient. 38
22235169 2011
568
Strongyloides duodenitis: case report and review of literature. 38
21329250 2011
569
Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients. 38
21412582 2011
570
Gastric perforation caused by Strongyloides stercoralis: a case report. 38
21341143 2011
571
[Clinical microbiology laboratory and imported parasitic diseases]. 38
20932605 2010
572
Strongyloidiasis: prevalence, risk factors, clinical and laboratory features among diarrhea patients in Ibadan Nigeria. 38
21735994 2010
573
Two donor-related infections in a heart transplant recipient: one common, the other a tropical surprise. 38
20888254 2010
574
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. 38
20644115 2010
575
Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe. 38
21036850 2010
576
Albendazole stimulates the excretion of strongyloides stercoralis Larvae in stool specimens and enhances sensitivity for diagnosis of strongyloidiasis. 38
20844212 2010
577
Detergent fraction of heterologous antigen to detect IgA and IgG in strongyloidiasis using saliva and serum paired samples. 38
20816697 2010
578
Non-oral treatment with ivermectin for disseminated strongyloidiasis. 38
20889884 2010
579
Pulmonary strongyloidiasis: time to wake up. 38
21510123 2010
580
Diagnostic yield of double-balloon enteroscopy with intestinal juice analysis for intestinal strongyloidiasis. 38
21175501 2010
581
Strongyloides stercoralis: there but not seen. 38
20733481 2010
582
Fatal Strongyloides stercoralis hyper-infection in a patient with multiple myeloma. 38
21221486 2010
583
Proteomic analysis of Strongyloides stercoralis L3 larvae. 38
20388238 2010
584
Strongyloides stercoralis infection in an HIV positive patient--a case report from RIMS, Imphal, Manipur. 38
22471190 2010
585
Molecular identification of the causative agent of human strongyloidiasis acquired in Tanzania: dispersal and diversity of Strongyloides spp. and their hosts. 38
20621633 2010
586
Strongyloidiasis-related deaths in the United States, 1991-2006. 38
20682893 2010
587
Asymptomatic Strongyloides stercoralis hyperinfection in an alcoholic patient with intense anemia. 38
20738204 2010
588
Gastrointestinal helminthiasis presenting with acute diarrhoea and constipation: report of two cases with a second pathology. 38
20962736 2010
589
A case of gastric and duodenal strongyloidiasis. 38
21509240 2010
590
Minimal change nephrotic syndrome in a patient with strongyloidiasis. 38
20224878 2010
591
Diarrhea due to parasites particularly Cryptosporidium parvum in great Cairo, Egypt. 38
21246951 2010
592
A new faecal antigen detection system for Strongyloides venezuelensis diagnosis in immunosuppressed rats. 38
20206167 2010
593
Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report. 38
20698992 2010
594
Disseminated strongyloidiasis caused by heart donor-to-host transmission presenting with purpura. 38
19886957 2010
595
Systemic lupus erythematosus and strongyloidiasis: a multifaceted connection. 38
20026523 2010
596
Eosinophilia and the seroprevalence of schistosomiasis and strongyloidiasis in newly arrived pediatric refugees: an examination of Centers for Disease Control and Prevention screening guidelines. 38
20400098 2010
597
Hydrophobic fractions from Strongyloides venezuelensis for use in the human immunodiagnosis of strongyloidiasis. 38
20356696 2010
598
Role of angiogenic factors in acute experimental Strongyloides venezuelensis infection. 38
20500674 2010
599
Evaluation of a rapid enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis. 38
20335415 2010
600
Acute hemorrhage from small bowel diverticula harboring strongyloidiasis and schistosomiasis. 38
20506887 2010
601
Patterns and risk factors of helminthiasis and anemia in a rural and a peri-urban community in Zanzibar, in the context of helminth control programs. 38
20485491 2010
602
Pancreatitis associated with Strongyloides stercoralis infection in a patient chronically treated with corticosteroids. 38
20444734 2010
603
Staphylococcus warneri meningitis in a patient with Strongyloides stercoralis hyperinfection and lymphoma: first report of a case. 38
20602029 2010
604
Uncomplicated strongyloidiasis in a liver transplant recipient on steroid-free immunosuppression. 38
20487417 2010
605
High prevalence of Strongyloides stercoralis among school children in rural Côte d'Ivoire. 38
19916629 2010
606
Strongyloides stercoralis hyperinfection in a diabetic patient: case report. 38
20562820 2010
607
Cryptosporidium and Strongyloides stercoralis infections among people with and without HIV infection and efficiency of diagnostic methods for Strongyloides in Yirgalem Hospital, southern Ethiopia. 38
20359359 2010
608
An enzyme-linked immunosorbent assay as screening tool for human intestinal capillariasis. 38
20578511 2010
609
Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment. 38
20003112 2010
610
Strongyloides stercoralis and the immune response. 38
19892034 2010
611
Faecal examination and PCR to detect Strongyloides venezuelensis in experimentally infected Lewis rats. 38
20209330 2010
612
Gastrointestinal manifestations in severe strongyloidiasis: report of 3 cases and literature review. 38
20578478 2010
613
The drugs we have and the drugs we need against major helminth infections. 38
20627144 2010
614
Factors affecting recovery of Strongyloides stercoralis larvae: an approach to a newly modified formalin-ether concentration technique for diagnosis of strongyloidiasis. 38
19923489 2010
615
Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view. 38
19892301 2009
616
An unusual presentation of alveolar hemorrhage. 38
19756329 2009
617
ELISA-based coproantigen in human strongyloidiaisis: a diagnostic method correlating with worm burden. 38
20120743 2009
618
Strongyloides stercoralis in a bronchial washing specimen processed as conventional and Thin-Prep smears: report of a case and a review of the literature. 38
19530103 2009
619
Screening practices for infectious diseases among Burmese refugees in Australia. 38
19891864 2009
620
Strongyloidiasis in transplant patients. 38
19807271 2009
621
Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient. 38
19843038 2009
622
Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases. 38
19501008 2009
623
Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. 38
19762378 2009
624
Strongyloidiasis--the most neglected of the neglected tropical diseases? 38
19328508 2009
625
Disseminated strongyloidiasis in immunocompromised patients--report of three cases. 38
19702983 2009
626
Reemergence of strongyloidiasis, northern Italy. 38
19788836 2009
627
Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. 38
19333553 2009
628
Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy. 38
19635888 2009
629
Pulmonary strongyloidiasis. 38
20329418 2009
630
Identification of the nuclear receptor DAF-12 as a therapeutic target in parasitic nematodes. 38
19497877 2009
631
The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. 38
19407128 2009
632
Evaluation of an enzyme-linked immunoelectrotransfer blot test for the confirmatory serodiagnosis of human toxocariasis. 38
19547865 2009
633
Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? 38
19407125 2009
634
[Strongyloides stercoralis infestation in an immunocompetent 82-year-old woman]. 38
19406508 2009
635
Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. 38
19144097 2009
636
[Disseminated strongyloidiasis with parasitemia in a patient under corticosteroid-treatment]. 38
19108967 2009
637
[A case of severe strongyloidiasis]. 38
19856518 2009
638
Strongyloides colitis is a lethal mimic of ulcerative colitis: the key morphologic differential diagnosis. 38
19144377 2009
639
Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. 38
19144095 2009
640
Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics. 38
18804829 2009
641
Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelines. 38
19270293 2009
642
Strongyloides hyperinfection syndrome in British veterans. 38
19208298 2009
643
Consequences of captivity: health effects of far East imprisonment in World War II. 38
18854350 2009
644
Strongyloidiasis: endoscopic diagnosis. 38
18955162 2009
645
Specific IgA and IgG antibodies in paired serum and breast milk samples in human strongyloidiasis. 38
19007741 2009
646
Fatal strongyloidiasis in three kidney recipients in Kuwait. 38
19648767 2009
647
Human strongyloidiasis: often brushed under the carpet. 38
19624080 2009
648
Intestinal strongyloidiasis as a presenting symptom of HTLV-1-associated adult T-cell leukemia/lymphoma. 38
19866424 2009
649
Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered Ivermectin. 38
20798874 2009
650
[An overview of Strongyloides stercoralis and its infections]. 38
19334396 2009
651
A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate. 38
19127333 2008
652
Screening African HIV positive patients for imported parasitic infections. 38
19000638 2008
653
Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatment. 38
19000386 2008
654
[Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate]. 38
19245164 2008
655
Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I. 38
19265619 2008
656
Spiral enteroscopy with the new DSB overtube: a novel technique for deep peroral small-bowel intubation. 38
19065477 2008
657
[Current pathologies among asylum seekers in Montreal: prevalence and associated risk factors]. 38
19149395 2008
658
Respiratory infections unique to Asia. 38
18945321 2008
659
Mucocutaneous Splendore-Hoeppli phenomenon. 38
18976399 2008
660
Severe strongyloidiasis in AIDS: is steroid therapy guilty again? 38
18978478 2008
661
[Evaluation of the humoral immune response to Strongyloides venezuelensis antigens]. 38
19142446 2008
662
Strongyloides Stercoralis infection associated with repititive bacterial meningitis and SIADH: a case report. 38
19317285 2008
663
Strongyloides stercoralis: a field-based survey of mothers and their preschool children using ELISA, Baermann and Koga plate methods reveals low endemicity in western Uganda. 38
18416881 2008
664
Atypical gastric presentation of strongyloidiasis in an immunecompetent patient. 38
18991212 2008
665
Effective diagnostic tests and anthelmintic treatment for Strongyloides stercoralis make community control feasible. 38
21061942 2008
666
Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia. 38
19143887 2008
667
Strongyloidiasis in personnel of the Regional Assistance Mission to Solomon Islands (RAMSI). 38
18707563 2008
668
[Allergic bronchopulmonary aspergillosis associated with strongyloidiasis]. 38
18771224 2008
669
Strongyloides hyperinfection syndrome complicating (ectopic) Cushing syndrome. 38
18580721 2008
670
[Ivermectin as a therapeutic alternative in neurocysticercosis that is resistant to conventional pharmacological treatment]. 38
18509826 2008
671
The present status of human helminthic diseases in Iran. 38
18510809 2008
672
HIV-1/parasite co-infection and the emergence of new parasite strains. 38
18371236 2008
673
Neglected infections of poverty in the United States of America. 38
18575621 2008
674
Pulmonary strongyloidiasis mimicking cancer symptoms: a case of hyperinfection in a patient with metastatic lung cancer. 38
18525313 2008
675
Dissemination of Strongyloides stercoralis in a patient with systemic lupus erythematosus after initiation of albendazole: a case report. 38
18479527 2008
676
Racial disparities in infection-related mortality at Alice Springs Hospital, Central Australia, 2000--2005. 38
18484927 2008
677
Strongyloides venezuelensis: the antigenic identity of eight strains for the immunodiagnosis of human strongyloidiasis. 38
18226812 2008
678
Strongyloides stercoralis infection in the immunocompromised host. 38
18462583 2008
679
Strongyloides hyperinfection syndrome after intestinal transplantation. 38
17605735 2008
680
Adult T-cell leukaemia and strongyloidiasis. 38
18302660 2008
681
Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. 38
18350608 2008
682
A fatal case of gram negative bacterial sepsis associated with disseminated strongyloidiasis in an immunocompromised patient. 38
18333531 2008
683
Strongyloides stercoralis: a rare cause of obstructive duodenal stenosis. 38
18446028 2008
684
Immunocompromised group differences in the presentation of intestinal strongyloidiasis. 38
18219126 2008
685
[Fulminant strongyloidiasis successfully treated by subcutaneous ivermectin: an autopsy case]. 38
18386629 2008
686
Strongyloidiasis: a review and update by case example. 38
18507302 2008
687
Parasitological and immunological diagnosis of Strongyloides stercoralis in patients with gastrointestinal cancer. 38
17852953 2008
688
Strongyloides ratti: in vitro and in vivo activity of tribendimidine. 38
18235851 2008
689
Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. 38
18023151 2008
690
[Disseminated strongyloidiasis: diagnosis and treatment]. 38
25310164 2007
691
Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma. 38
17641892 2007
692
The occurrence of severe infections with Rhabditis axei in AIDS patients in Iran. 38
17640397 2007
693
Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. 38
17940124 2007
694
High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. 38
17968826 2007
695
Steptococcus bovis meningitis and sepsis associated with Strongyloidiasis in an immunocompetent patient. 38
18309863 2007
696
Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection. 38
18416349 2007
697
Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis. 38
18078583 2007
698
Persistent and untreated tropical infectious diseases among Sudanese refugees in the United States. 38
17978062 2007
699
Immune reconstitution disease associated with parasitic infections following initiation of antiretroviral therapy. 38
17762781 2007
700
Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. 38
17875514 2007
701
Ivermectin resistance and overview of the Consortium for Anthelmintic Resistance SNPs. 38
23489032 2007
702
IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen. 38
17610082 2007
703
Identification of a 26-kDa protein fraction as an important antigen for application in the immunodiagnosis of strongyloidiasis. 38
17569087 2007
704
Strongyloides stercoralis hyper-infection syndrome in HIV+/AIDS patients in Iran. 38
17401580 2007
705
Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings. 38
19372909 2007
706
[Animal helminthisms and their zonal prevalence in the Orenburg Region]. 38
17912835 2007
707
Seroepidemiological aspects of human Strongyloides stercoralis infections in Chile. 38
17823755 2007
708
Optimum methods of inactivation of Strongyloides stercoralis larvae from reclaimed wastewater. 38
17106779 2007
709
Evaluation of strongyloidiasis in kennel dogs and keepers by parasitological and serological assays. 38
17448603 2007
710
Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. 38
17551383 2007
711
Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. 38
17524758 2007
712
Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait. 38
17524878 2007
713
How to diagnose and manage common parasitic pneumonias. 38
17414130 2007
714
Syndrome of inappropriate secretion of antidiuretic hormone associated with strongyloidiasis. 38
17539272 2007
715
[Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report]. 38
17515677 2007
716
Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up. 38
17135451 2007
717
Parasitic colitides. 38
20011360 2007
718
Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans. 38
17151215 2007
719
[Finding of Strongyloides stercoralis infection, 25 years after leaving the endemic area, upon corticotherapy for ocular trauma]. 38
17318103 2007
720
Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. 38
16533536 2007
721
Changing faces: A review of infectious disease screening of refugees by the Migrant Health Unit, Western Australia in 2003 and 2004. 38
17181502 2006
722
Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome. 38
16949135 2006
723
Histopathology of gastric and duodenal Strongyloides stercoralis locations in fifteen immunocompromised subjects. 38
17149952 2006
724
Minimal change nephrotic syndrome in association with strongyloidiasis. 38
17176919 2006
725
New trends in diagnosis and treatment of chronic intestinal strongyloidiasis stercoralis in Egyptian patients. 38
17153698 2006
726
Ivermectin: uses and impact 20 years on. 38
17075336 2006
727
Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. 38
17042934 2006
728
Arthritis associated with Strongyloides stercoralis infection in HLA B-27-positive African. 38
16738888 2006
729
Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. 38
16551471 2006
730
Severe strongyloidiasis in corticosteroid-treated patients. 38
16961629 2006
731
[Enterococcal meningitis due to strongyloidiasis with HTLV-1 carrier]. 38
17323782 2006
732
Strongyloides stercoralis: risks posed to immigrant patients in an Australian tertiary referral centre. 38
16958639 2006
733
[Intestinal parasitosis in French West Indies: endemic evolution from 1991 to 2003 in the University Hospital of Pointe-a-Pitre, Guadeloupe]. 38
17111973 2006
734
Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation. 38
16845427 2006
735
Risk factors for strongyloidiasis hyperinfection and clinical outcomes. 38
17333728 2006
736
Long-term prurigo in a returned expatriate with chronic strongyloidiasis. 38
16911412 2006
737
Strongyloidiasis stercoralis: is it a health problem in Saudi Arabia? 38
17366869 2006
738
Unsuspected strongyloidiasis in hospitalised elderly patients with and without eosinophilia. 38
16842575 2006
739
[Therapeutic alternatives in case of failure of first-line treatment of intestinal helminthiasis in adults]. 38
16999037 2006
740
Not your typical strongyloides infection: a literature review and case study. 38
16929879 2006
741
Is there an association between positive Strongyloides stercoralis serology and diabetes mellitus? 38
16872576 2006
742
Strongyloides stercoralis mesenteric lymphadenopathy: clue to the etiopathogenesis of intestinal pseudo-obstruction in HIV-infected patients. 38
16844562 2006
743
Exposure of medical staff to Strongyloides stercolaris from a patient with disseminated strongyloidiasis. 38
16944262 2006
744
Strongyloidiasis with gastric mucosal invasion presenting with acute interstitial nephritis. 38
17121287 2006
745
Strongyloidiasis hyperinfection in a patient with membranoproliferative glomerulonephritis. 38
16855328 2006
746
[Strongyloides stercoralis and HIV: a case report of an indigenous disseminated infection from non-endemic area]. 38
17152211 2006
747
Intestinal damage in strongyloidiasis: the imbalance between cell death and proliferation. 38
16865572 2006
748
Intestinal strongyloidiasis and hyperinfection syndrome. 38
16734908 2006
749
Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee. 38
16645520 2006
750
Prevalence of geohelminths in savana and forest areas of Côte d'Ivoire. 38
16918183 2006
751
[Treatment of cosmopolitan parasitic diseases]. 38
16775947 2006
752
Adults with spontaneous aerobic Gram-negative bacillary meningitis admitted to the intensive care unit. 38
16451418 2006
753
Parasitological and serological diagnosis of Strongyloides stercoralis in domesticated dogs from southeastern Brazil. 38
16321470 2006
754
Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. 38
16553594 2006
755
Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies. 38
16242280 2006
756
Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. 38
16474078 2006
757
Potential use of Trichinella spiralis antigen for serodiagnosis of human capillariasis philippinensis by immunoblot analysis. 38
16333664 2006
758
Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus. 38
16622724 2006
759
[Intestinal parasitosis in patients with HIV-AIDS]. 38
16622484 2006
760
A rare intestinal manifestation in a patient with common variable immunodeficiency and strongyloidiasis. 38
16682801 2006
761
Seroepidemiology of strongyloidiasis in the Peruvian Amazon. 38
16407351 2006
762
Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. 38
16418832 2006
763
Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis. 38
17547048 2006
764
[Strongyloides stercoralis: histopathological findings of duodenal mucosa (1999-2005)]. 38
16622487 2006
765
Comment on: Strongyloidiasis: a mistaken diagnosis and a fatal outcome in a patient with diarrhoea. 38
16260016 2006
766
Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India. 38
16517998 2005
767
Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. 38
16282302 2005
768
Fatal stongyloides hyperinfection in heart transplantation. 38
16297809 2005
769
Strongyloidiasis presenting as duodenal obstruction. 38
16737052 2005
770
Gastrointestinal parasites in the immunocompromised. 38
16148530 2005
771
Disseminated Strongyloides stercoralis in AIDS: a report from India. 38
16366097 2005
772
Diarrhoea and rash in a retired farmer. 38
16219960 2005
773
Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: a pathognomonic feature of potentially lethal disease? 38
16410894 2005
774
Comparison of albendazole regimen for prophylaxis of strongyloides hyperinfection in nephrotic syndrome patients on long-term steroids in Cambodia. 38
16354470 2005
775
Preventing strongyloidiasis in the immunosuppressed. 38
16394469 2005
776
Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. 38
16148135 2005
777
[Intestinal and disseminated strongyloidosis: two case studies]. 38
16327659 2005
778
Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. 38
16041520 2005
779
Strongyloidiasis: a review of the evidence for Australian practitioners. 38
16048468 2005
780
Oral ivermectin for the treatment and prophylaxis of scabies in prison. 38
16096178 2005
781
Severe gastrointestinal strongyloidiasis. 38
16082494 2005
782
Expression of cytokines and monosaccharide transporters in the duodenal mucosa of patients with gastrointestinal symptoms in rural Thailand. 38
16295547 2005
783
Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. 38
15937753 2005
784
Comparative assessment of the gelatin particle agglutination test and an enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis. 38
16000448 2005
785
A case of fatal hyperinfective strongyloidiasis with discovery of autoinfective filariform larvae in sputum. 38
15951639 2005
786
[Purpura in patient with disseminated strongiloidiasis]. 38
15895179 2005
787
Intestinal strongyloidiasis and common variable immunodeficiency syndrome. 38
15876606 2005
788
Clinical characteristics and treatment of constrictive pericarditis in Taiwan. 38
15791042 2005
789
Ancylostoma duodenale infection: a study of serum immunoglobulin G4 response to the excretory secretory antigen of adult worm. 38
15880990 2005
790
Parasitic central nervous system infections in immunocompromised hosts. 38
15824993 2005
791
[Recurrent strongyloidiasis as an indicator of HTLV-1 infection]. 38
15830313 2005
792
Comparison of the quantitative formalin ethyl acetate concentration technique and agar plate culture for diagnosis of human strongyloidiasis. 38
15815023 2005
793
Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology. 38
15790710 2005
794
Intestinal strongyloidiasis: recognition, management, and determinants of outcome. 38
15718861 2005
795
Fatal meningoencephalitis caused by disseminated strongyloidiasis. 38
15835286 2005
796
Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. 38